"VAR","Variable","UNIT","Measure","COU","Country","YEA","Year","Value","Flag Codes","Flags"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",145.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",151.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",153.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",150,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",151.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",151.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",149.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",149.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",150.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",144.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",139.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",143.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",146.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",154.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",161.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",168.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",175.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",171.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",155.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",149.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",143.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",144.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",148.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",147.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",148.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",153.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",159.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",165.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",170.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",177.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",189,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",174.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",181.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",187.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",189.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",192.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",107.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",111.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",112.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",114.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",117.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",119.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",196,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",198.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",203.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",210.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",235.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",263.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",285.1,"D; P","Difference in methodology; Provisional value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",236.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",240.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",246.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",256,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",259.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",281,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",285.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",292.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",306.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",303.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",337,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",353.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",154.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",157.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",163.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",165.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",169.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",174.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",178,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",180.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",181.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",186,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",194.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",202.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",312,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",314,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",309.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",305.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",306.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",305.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",307.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",302.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",305.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",315,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",326.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",334.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",135,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",142.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",154.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",161.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",163.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",166.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",172.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",171.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",169.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",176.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",170.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",177,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",183.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",190.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",217,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",221.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",227,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",228.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",232.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",227.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",228.9,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",230.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",232.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",237.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",168.2,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",175.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",186.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",214.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",252.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",270.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",300.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",356.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",342.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",200.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",214.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",221.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",234.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",247.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",256,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",269.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",271.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",280.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",295.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",373.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",411.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",403.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",146.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",133,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",137,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",144.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",146.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",155.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",164,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",170.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",174.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",178.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",186.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",194.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",195.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",207.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",218.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",235,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",248.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",267.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",287.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",307.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",327.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",334.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",290,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",318.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",317.6,"E","Estimated value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",278.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",240.6,"B","Break"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",245.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",330.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",422.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",370,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",217.5,"B","Break"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",219.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",223.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",256,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",315.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",325.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",249.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",303,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",360.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",396.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",415.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",453.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",465.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",460.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",432.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",446.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",477.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",559.1,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",516.2,"D; P","Difference in methodology; Provisional value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",220.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",231.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",233.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",255.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",272.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",289.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",305.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",314.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",319.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",326.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",332.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",337.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",354.3,"E","Estimated value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",344.7,"E","Estimated value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",325.5,"E","Estimated value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",344.7,"E","Estimated value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",340,"E","Estimated value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",257.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",252.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",256,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",257.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",264.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",270.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",279.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",289,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",275.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",263.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",269.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",283.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",298.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",180.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",175.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",184.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",196.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",203.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",211.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",222.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",221.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",228.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",242.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",265.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",275,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",284.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",305.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",300,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",283.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",321.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",335.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",356,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",271,"B","Break"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",275.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",269.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",266.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",281.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",295.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",231.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",235.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",238,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",231.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",230.8,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",235.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",271.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",283,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",301.1,"B","Break"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",312,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",268,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",286.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",299.5,"P","Provisional value"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",247.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",244,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",243.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",248.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",252.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",259.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",263.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",265.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",268.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",275.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",277.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",275.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",283.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",147,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",170.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",185.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",199.1,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",224,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",286.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",332.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",340.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",387.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",392.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",417.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",441.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",187.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",196.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",206.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",219.3,"B; D","Break; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",226.5,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",232,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",235.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",241.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",242.4,"E; D","Estimated value; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",248.9,"E; D","Estimated value; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",251.8,"E; D","Estimated value; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",271.6,"E; D","Estimated value; Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",110.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",118.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",138.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",144.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",166.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",105.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",108.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",133.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",141.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",204.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",228.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",249.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",115.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",122.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",135.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",143,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",151.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",160.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",165.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",169.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",174.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",176.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",183.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",186,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",195.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",110.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",148.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",158.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",198,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",181.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",173.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",172.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",178.8,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",176,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",182.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",160.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",171.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",177.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",184.4,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",188.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",198.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",210.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",221.6,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",233.2,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",249.7,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",281.9,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",300.3,"D","Difference in methodology"
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",304.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",1.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",1.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",1.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",7.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",7.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",7.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",7.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",7.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",8.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",8.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",9.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",9.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",10.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",2.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",2.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",2.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",2.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",2.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",0.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",0.7,"B; D","Break; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",0.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",0.9,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",0.9,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",5.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",0.8,"B; D","Break; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",1.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",1.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",1.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",1.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",1.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",1.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",2.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",2.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",4.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",1.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",1.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",2.6,"E","Estimated value"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",2.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",3.7,"B","Break"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",3.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",4.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",4.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",4.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",3.1,"B","Break"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",3.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",3.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",3.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",4.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",4.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",0,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",0,"E","Estimated value"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",0,"E","Estimated value"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",0,"E","Estimated value"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",0,"E","Estimated value"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",0,"E","Estimated value"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",1.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",1.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",1.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",1.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",1.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",1.5,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",0.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",0,"B","Break"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",2.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",2.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",1.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",1.8,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",2.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",2.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",2.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",2.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",2.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",2.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",2.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",2.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",2.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",2.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",2.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",0.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",0.6,"B; D","Break; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",0.1,"E; D","Estimated value; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",0.1,"E; D","Estimated value; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",0,"E; D","Estimated value; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",0,"E; D","Estimated value; Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",0.9,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",1.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",1.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",1.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",1.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",1.4,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",0.1,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",0.2,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",0.3,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",0.4,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",0.5,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",0.6,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",0.7,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",0.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",0.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",0.8,"D","Difference in methodology"
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",0.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",68.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",71.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",73.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",76.2,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",77.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",77.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",78,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",77.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",76,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",68.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",62.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",63.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",63.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",66.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",67.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",68.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",68.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",66.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",45.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",35.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",33.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",32.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",30.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",29.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",79.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",83.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",87.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",91.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",95.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",100.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",108.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",92.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",97.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",100,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",99.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",102.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",38.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",39.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",40.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",42.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",46.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",48.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",73.8,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",73.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",73.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",74,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",76.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",79.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",77.6,"D; P","Difference in methodology; Provisional value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",51.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",55.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",58.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",60.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",65.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",69.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",73.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",74.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",75.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",79.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",78.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",81.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",51.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",55.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",58.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",60.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",63.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",66.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",68.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",68.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",68.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",69.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",72.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",74.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",52.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",57.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",60.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",63.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",66.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",65.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",65.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",66.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",67.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",68.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",70.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",72.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",62.1,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",68,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",74.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",79.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",81.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",83.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",87.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",87.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",85,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",89.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",84.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",89.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",69.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",75.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",81.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",85.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",90.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",93.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",94.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",88.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",85.6,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",84.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",83.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",83.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",57.8,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",57.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",62.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",72.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",74.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",75.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",83.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",88.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",90.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",61,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",65.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",63.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",57.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",62.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",67.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",69.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",71.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",76,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",79.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",95,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",95.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",96.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",80.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",76.3,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",79.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",84,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",86.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",91.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",98.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",102.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",106.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",109,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",114,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",117.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",114.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",74.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",80.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",84.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",86.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",84.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",79.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",77.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",77.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",79.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",81,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",84.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",83.5,"E","Estimated value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",34.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",37.8,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",39.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",42.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",45.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",46.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",41.8,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",43,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",46.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",61.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",75.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",81.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",72.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",77.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",80.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",82.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",85.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",89.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",90.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",87.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",87.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",88.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",87.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",88.5,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",81.2,"D; P","Difference in methodology; Provisional value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",88.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",99.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",94.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",104,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",110.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",117,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",124.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",125.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",126.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",128.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",128.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",128.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",98.9,"E","Estimated value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",100.1,"E","Estimated value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",94.2,"E","Estimated value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",103.3,"E","Estimated value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",110.2,"E","Estimated value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",45,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",47.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",50.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",53.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",56.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",59.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",62.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",65.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",67.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",70.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",72,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",74.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",76.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",73,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",73.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",78.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",90.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",92.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",94.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",96.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",92,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",93.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",102.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",104.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",107.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",111.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",32.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",35.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",34.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",40.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",45,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",45.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",46.4,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",46.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",47.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",47.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",48.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",50.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",116.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",120.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",120.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",121.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",125.2,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",124.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",125.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",123.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",125.3,"B","Break"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",127.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",128.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",134.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",137.8,"P","Provisional value"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",59.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",63.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",67.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",70.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",73.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",76.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",79.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",80.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",80,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",82.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",83,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",85.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",87.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",45.9,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",50.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",53.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",53,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",54.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",59.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",59.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",66.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",75.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",76.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",76.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",83,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",71.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",77.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",84.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",93.2,"B; D","Break; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",98.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",103.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",106.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",109.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",111.3,"E; D","Estimated value; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",114.3,"E; D","Estimated value; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",115.2,"E; D","Estimated value; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",118.1,"E; D","Estimated value; Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",50.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",58.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",63.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",62.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",73.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",42.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",52.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",54.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",52.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",79.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",81.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",69.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",23.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",26.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",30.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",33.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",38.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",42.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",46,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",48.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",52,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",56.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",61.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",61.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",65.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",52.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",62,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",64.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",65.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",65.3,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",63.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",65.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",66.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",66.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",68.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",54.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",57.5,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",58.2,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",58.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",58.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",62,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",65.7,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",67.8,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",70.1,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",72.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",73.6,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",79.4,"D","Difference in methodology"
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",83.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",57.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",59.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",60.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",57.5,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",57.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",57.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",56.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",57.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",57.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",57.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",60,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",62.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",45.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",46.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",45.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",46,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",46.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",46.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",46.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",47.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",46.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",47.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",49.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",49.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",60.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",61.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",63.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",65,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",66.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",68,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",70,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",71,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",72.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",75.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",78,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",77.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",55.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",57,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",57.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",58.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",58.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",58.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",79,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",81.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",84.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",86.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",104.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",124.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",154.7,"D; P","Difference in methodology; Provisional value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",73.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",76.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",78.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",80.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",84.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",88,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",88.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",89.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",90.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",92.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",94.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",97.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",47.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",49,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",50.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",51.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",51.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",53,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",54.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",55.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",57,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",58.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",62,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",67,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",83.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",84.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",84.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",85.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",88.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",89.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",92.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",91.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",95.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",99.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",101.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",105.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",72.9,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",74.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",80.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",81.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",81.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",82.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",84.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",84,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",84.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",86.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",85.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",87.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",81.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",82.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",83.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",83.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",83.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",82.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",83.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",83.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",85.9,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",88.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",91,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",93.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",85,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",83.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",86.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",80.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",81.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",83.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",88.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",100.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",98.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",70.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",74.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",75.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",77.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",76.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",69.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",72.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",74.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",75.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",77,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",79.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",76.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",75.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",31.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",38.1,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",38.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",41.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",42.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",44.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",46.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",47.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",48,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",48.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",51.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",54.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",57.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",61.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",62,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",62.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",61.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",62,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",62.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",62.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",63,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",64,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",64.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",65.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",67.2,"E","Estimated value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",65.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",64.1,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",64.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",65.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",60.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",61.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",60.3,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",63.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",65.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",67.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",72.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",78.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",63.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",64,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",63.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",64,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",64.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",65.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",64.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",64.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",64,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",65.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",64.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",63.8,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",60,"D; P","Difference in methodology; Provisional value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",72.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",72.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",74.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",75.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",75,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",75.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",76.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",77.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",75.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",76.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",77.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",78.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",57,"E","Estimated value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",57.2,"E","Estimated value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",53,"E","Estimated value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",54.9,"E","Estimated value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",52.3,"E","Estimated value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",48.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",48.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",48.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",48.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",50.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",51.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",53,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",55.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",56.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",58.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",59.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",65.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",76.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",62.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",58.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",61,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",62.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",64.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",67.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",68.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",67.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",70.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",74.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",76.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",78.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",85,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",57.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",61.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",58,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",65.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",70.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",75.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",76.3,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",76,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",76.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",78.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",80.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",79.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",55.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",56,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",66.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",66.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",71.1,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",72.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",75.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",76.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",78.1,"B","Break"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",79.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",81.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",84.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",88.6,"P","Provisional value"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",51.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",53,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",53.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",55.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",56.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",58.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",60.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",62.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",64.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",67.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",70.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",73.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",80.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",47.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",53.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",56.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",58.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",61.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",64.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",66.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",72.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",75.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",79.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",91.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",96.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",74.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",77.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",79.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",82.3,"B; D","Break; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",83.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",84.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",85.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",84.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",72.1,"E; D","Estimated value; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",74.2,"E; D","Estimated value; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",74.3,"E; D","Estimated value; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",90,"E; D","Estimated value; Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",34,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",30.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",45.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",52.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",59.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",46.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",39.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",47.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",48,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",73.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",77.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",79.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",45.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",47.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",53.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",54.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",57.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",59.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",61.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",62.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",64.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",65,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",66.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",67.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",73.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",36.8,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",55.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",59.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",62.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",64.4,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",62.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",61.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",59.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",60,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",66.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",63.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",67.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",70.5,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",73.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",74.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",75.9,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",78.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",80.7,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",82.6,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",83.3,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",85.1,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",87.2,"D","Difference in methodology"
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",91.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",44.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",43.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",43.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",44.1,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",45,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",46.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",35.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",36.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",37.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",37.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",38.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",39.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",45.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",46.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",47.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",48.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",51.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",50.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",51.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",51.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",53.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",51.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",51.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",51.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",90.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",95.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",99,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",101.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",104.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",106.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",109.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",112.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",114.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",115.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",112.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",115.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",64.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",61.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",60.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",61.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",60.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",64.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",86.3,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",95.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",96.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",98.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",98.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",101.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",101.5,"D; P","Difference in methodology; Provisional value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",198.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",193.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",189.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",186.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",191,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",193.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",198.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",203,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",204.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",206.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",205.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",227,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",118.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",119.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",120.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",116.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",116.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",116,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",114.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",114.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",114.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",115.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",116.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",118.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",145,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",143.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",144.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",145.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",143.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",143.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",138.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",137.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",135.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",136.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",140.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",146.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",173.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",179.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",179.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",174.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",178.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",174.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",197.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",200.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",210.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",211.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",215.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",225.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",59.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",62.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",65.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",68.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",72.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",75.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",77.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",78.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",107.6,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",112.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",116,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",117.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",182.2,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",176.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",185.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",223.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",239.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",247.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",260.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",274.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",280.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",86,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",92.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",80.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",78,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",82.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",87.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",91.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",96.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",100.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",104.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",109.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",109.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",110.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",105.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",97.6,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",96.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",98.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",94.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",99.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",107,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",111.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",108.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",111.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",118.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",120.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",111.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",154.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",146,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",117.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",116.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",118.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",122.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",125.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",129.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",136.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",137.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",140.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",142.4,"E","Estimated value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",80.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",86.1,"B","Break"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",86.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",90.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",96.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",87.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",79.9,"B","Break"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",81.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",83.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",85.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",90.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",93.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",105.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",109.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",116.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",118.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",125.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",127.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",138.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",152.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",161,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",170.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",176.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",196.8,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",190,"D; P","Difference in methodology; Provisional value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",126.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",129.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",131.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",133,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",134.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",135.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",137.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",141.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",143.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",142.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",141.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",141.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",293.9,"E","Estimated value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",270.6,"E","Estimated value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",236.6,"E","Estimated value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",253.2,"E","Estimated value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",247.5,"E","Estimated value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",136.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",138.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",141.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",143.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",141.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",140,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",143.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",144.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",148.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",151.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",152.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",156.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",166.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",93.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",95.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",88.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",83.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",85.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",87.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",90.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",90.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",93.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",94.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",93.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",93.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",95.7,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",133.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",134.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",128.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",143.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",149.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",155.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",289,"B","Break"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",288,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",290,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",297.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",299.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",305.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",120.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",123.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",125.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",123.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",133.2,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",137.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",149.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",159.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",170.5,"B","Break"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",177,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",114.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",121,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",125,"P","Provisional value"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",338.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",334,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",306.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",284.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",266.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",258.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",256.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",251.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",235.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",229.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",224.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",225.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",225.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",87.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",96.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",107.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",111.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",118,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",124.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",134.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",144.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",169.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",170.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",152.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",188.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",165.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",169,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",176.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",187.6,"B; D","Break; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",193.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",196.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",204.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",223.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",242.9,"E; D","Estimated value; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",245.3,"E; D","Estimated value; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",244.8,"E; D","Estimated value; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",243,"E; D","Estimated value; Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",64.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",122.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",107.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",157,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",159.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",157.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",87.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",106.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",121.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",196.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",202.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",200.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",67.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",75,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",91.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",95.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",101,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",101.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",105.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",107.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",110.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",107.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",109.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",112.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",116.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",118.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",136.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",128.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",138.4,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",68.3,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",82.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",71,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",73,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",78.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",75.1,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",83.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",87.2,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",90.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",95,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",101,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",103.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",104.9,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",105.6,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",106.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",106.5,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",106.8,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",109,"D","Difference in methodology"
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",109.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",390.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",392.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",389.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",388.1,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",380.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",376.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",371.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",368.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",371.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",371.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",383.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",395.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",345.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",351.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",350.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",345.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",346.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",333.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",320.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",319.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",320.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",330.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",333.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",306,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",486.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",488.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",492.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",491.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",487.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",486.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",487,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",477.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",474.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",476.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",479.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",483.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",415.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",424.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",424.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",421.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",419.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",419.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",440.3,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",446.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",461.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",477.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",493.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",509,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",507.9,"D; P","Difference in methodology; Provisional value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",590,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",589,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",596.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",595.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",609.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",615.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",612.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",614.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",604.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",617.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",623.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",633.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",511.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",519.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",530.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",539,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",545,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",551.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",549.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",550.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",567.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",597.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",626.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",652.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",532,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",530.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",540.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",548.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",552.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",559.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",559.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",574.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",598.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",626.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",655.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",683,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",428,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",437,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",444.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",437.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",431.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",433.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",437.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",434.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",428,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",453.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",445.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",439.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",635.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",648.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",659.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",668.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",683.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",688.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",695.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",695.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",719.9,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",754.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",781.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",799.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",430.8,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",411.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",420.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",443.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",448.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",453.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",471.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",472.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",482.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",690.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",710.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",703.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",713.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",718.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",723.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",721.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",722.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",724.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",726.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",754.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",722.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",721.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",351.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",363.6,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",364.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",372.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",367.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",373.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",376.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",376.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",380.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",381.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",388.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",390.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",380.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",476.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",480.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",483.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",482.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",481.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",484.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",484.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",487.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",497.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",503.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",503.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",505.5,"E","Estimated value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",204.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",208.5,"B","Break"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",211.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",217.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",212,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",212.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",208.9,"B","Break"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",213,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",218.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",221.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",240.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",254.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",344.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",353.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",355.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",352.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",347.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",343.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",336,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",322.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",316.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",318.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",307.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",304.3,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",278.8,"D; P","Difference in methodology; Provisional value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",410.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",421.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",432.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",435.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",437.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",438.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",441.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",447.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",450,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",453.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",451.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",455.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",409.5,"E","Estimated value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",415.7,"E","Estimated value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",400.2,"E","Estimated value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",460,"E","Estimated value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",460.8,"E","Estimated value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",408.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",408.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",410.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",413,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",414.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",417.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",421.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",424.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",432.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",446,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",459.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",475.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",496.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",408.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",388.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",399.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",396.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",392.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",389.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",390.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",385.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",390,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",410.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",421.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",427.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",441.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",608.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",626.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",605,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",683.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",683.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",680,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",551.7,"B","Break"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",543,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",534.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",532,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",537.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",526,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",401.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",408.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",401.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",390.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",417.4,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",423.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",431.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",434.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",444.6,"B","Break"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",448.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",452.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",462.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",469.5,"P","Provisional value"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",450.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",456.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",460.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",472.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",479.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",490.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",500.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",509.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",519.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",536.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",554.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",570.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",598.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",151.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",162.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",163.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",158.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",160.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",165.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",167.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",176.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",187.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",195.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",218.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",221.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",520.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",520.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",528.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",533.5,"B; D","Break; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",536.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",536.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",537.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",543.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",557.4,"E; D","Estimated value; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",565,"E; D","Estimated value; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",572.9,"E; D","Estimated value; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",575,"E; D","Estimated value; Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",200.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",356.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",300.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",522.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",464.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",441.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",379,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",360.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",476.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",576.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",601.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",593.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",351.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",358.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",399.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",402,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",408.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",416.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",411.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",418.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",429.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",429.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",448.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",449.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",471.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",253.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",334.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",330.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",336.6,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",325.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",317.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",316.7,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",311.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",306.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",306.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",523.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",534.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",540.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",549.1,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",549.8,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",553,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",556.3,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",557.2,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",555.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",558.4,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",562.5,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",563.9,"D","Difference in methodology"
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",574.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",3.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",3.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",3.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",3.1,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",2.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",2.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",2.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",1.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",1.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",0.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",0.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",0.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",2.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",1.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",0.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",2.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",1.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",1.5,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",0.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",0.8,"D; P","Difference in methodology; Provisional value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",3.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",3.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",2.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",2.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",2.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",2.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",2.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",4.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",4.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",4.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",4.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",3.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",3.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",3.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",2.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",4.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",3.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",3.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",2.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",2.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",2.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",2.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",2.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",2.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",1.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",1.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",1.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",1.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",6.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",5.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",5.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",4.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",4.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",3.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",3.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",3.1,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",2.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",3.1,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",4.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",4.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",3.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",3.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",3.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",2.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",2.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",1.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",1.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",2.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",2.3,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",2.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",1.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",1.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",3.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",3.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",2.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",1.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",1.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",1.3,"E","Estimated value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",1.4,"B","Break"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",1.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",1.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",1.1,"B","Break"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",1.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",1.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",1.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",0.9,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",0.8,"D; P","Difference in methodology; Provisional value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",2.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",2.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",2.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",1.7,"E","Estimated value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",1.6,"E","Estimated value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",1.5,"E","Estimated value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",1.5,"E","Estimated value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",1.5,"E","Estimated value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",1.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",1.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",1.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",1.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",0.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",4.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",3.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",3.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",3.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",2.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",3.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",2.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",2.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",2.4,"B","Break"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",2.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",1.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",4.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",4.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",3.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",3.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",3.3,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",3.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",2.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",2.4,"B","Break"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",1.6,"P","Provisional value"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",3.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",2.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",2.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",2.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",1.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",1.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",1.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",1.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",1.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",1.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",1.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",1.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",1.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",1.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",3.2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",2.8,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",2.7,"B; D","Break; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",2.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",2,"E; D","Estimated value; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",1.9,"E; D","Estimated value; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",1.8,"E; D","Estimated value; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",1.7,"E; D","Estimated value; Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",2.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",1.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",1.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",6.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",5.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",5.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",4.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",4.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",4.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",3.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",3.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",2.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",0.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",0.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",0.5,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",0.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",0.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",0.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",0.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",0.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",0.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",0.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",3.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",2.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",2.7,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",2.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",2.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",2.3,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",2.1,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",2,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",1.9,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",1.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",1.6,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",1.4,"D","Difference in methodology"
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",1.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",1.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",1.9,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",2.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",2.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",2.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",2.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",2.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",2.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",2.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",2.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",2.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",2.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",2.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",8.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",8.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",8.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",8.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",8.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",8.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",8.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",7.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",7.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",7.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",1.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",1.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",1.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",1.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",1.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",1.5,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",1.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",1.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",1.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",1.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",1.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",1.4,"D; P","Difference in methodology; Provisional value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",7.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",7.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",7.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",7.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",8.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",8.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",8.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",8.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",8.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",8.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",8.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",1.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",1.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",10.4,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",10.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",10,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",9.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",9.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",9.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",9.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",9.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",8.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",8.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",8.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",8.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",3,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",6.5,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",6.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",6.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",7.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",7.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",7.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",7.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",7.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",6.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",6.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",6.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",6.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",6.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",3.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",3.6,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",3.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",3.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",4.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",4.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",4.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",4.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",4.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",4.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",4.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",4.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",8.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",8.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",8.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",8.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",7.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",7.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",7.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",7.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",7.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",7.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",7.7,"E","Estimated value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",0.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",0.9,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",1.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",1.1,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",1.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",1.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",7.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",7.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",7.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",7.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",7.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",7.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",6.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",6.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",6.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",6.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",6.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",6.3,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",5.7,"D; P","Difference in methodology; Provisional value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",2.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",2.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",2.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",2.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",2.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",2.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",1.5,"E","Estimated value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",1.5,"E","Estimated value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",1.6,"E","Estimated value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",1.6,"E","Estimated value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",1.7,"E","Estimated value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",1.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",2.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",2.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",2.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",2.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",2.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",2.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",2.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",2.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",6.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",6.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",6.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",5.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",5.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",5.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",5.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",4.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",4.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",4.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",4.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",7.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",8.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",8.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",9.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",10,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",10.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",10.4,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",10.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",10.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",10.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",10.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",10.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",3.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",2.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",3.2,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",3.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",3.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",3.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",3.2,"B","Break"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",3.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",3.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",3.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",3.2,"P","Provisional value"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",1.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",1.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",1.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",1.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",1.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",1.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",1.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",0.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",0.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",0.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",0.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",0.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",0.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",1.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",1.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",1.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",1.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",1.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",1.6,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",1.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",1.4,"B; D","Break; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",1.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",1.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",1.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",1.3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",1.3,"E; D","Estimated value; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",1.3,"E; D","Estimated value; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",1.3,"E; D","Estimated value; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",1.2,"E; D","Estimated value; Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",1.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",2.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",2.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",1.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",1.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",1.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",1.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",1.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",2.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",5.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",6.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",6.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",7.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",6.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",6.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",6.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",5.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",5.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",3,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",3.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",3.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",3.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",3.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",3.7,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",3.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",3.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",4.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",4.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",4.5,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",4.4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",4.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",4.2,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",4.1,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",4,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",3.8,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",3.9,"D","Difference in methodology"
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",3.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",6.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",6.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",7.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",7.5,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",7.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",7.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",8.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",8.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",9.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",9.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",10,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",9.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",9.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",8.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",8.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",7.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",7.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",7.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",7.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",7.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",7.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",6.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",6.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",6.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",6.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",6.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",6.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",6.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",6.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",6.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",1.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",1.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",1.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",1.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",1.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",1.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",2.2,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",2.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",2.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",2.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",3.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",3.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",3.8,"D; P","Difference in methodology; Provisional value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",11.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",12.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",13.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",13.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",13.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",13.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",13.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",12.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",12.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",12,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",11.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",11,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",3.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",3.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",3.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",2.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",2.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",3.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",3.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",3.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",11.9,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",10.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",10.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",10.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",10.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",10.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",9.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",9.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",9.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",9.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",8.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",8.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",13.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",13.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",13.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",13.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",13.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",13.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",13.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",13.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",13.5,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",14,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",14.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",14.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",5.1,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",5.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",5.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",5.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",5.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",6.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",6.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",24.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",25.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",25.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",26.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",28.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",29.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",31,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",32.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",33.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",34.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",37.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",35.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",36.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",1.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",2.1,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",2.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",2.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",2.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",2.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",2.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",2.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",2.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",2.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",2.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",10.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",10.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",10.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",10.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",9.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",9.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",9.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",9.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",9.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",9.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",9.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",9.2,"E","Estimated value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",2.5,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",2.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",2.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",2,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",1.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",1.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",1.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",1.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",1.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",4.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",4.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",4.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",4.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",5.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",5.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",5.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",5.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",5.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",6.1,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",5.1,"D; P","Difference in methodology; Provisional value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",3.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",3.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",3.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",3.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",3.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",3.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",3.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",3.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",3.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",3.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",3.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",3.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",11.5,"E","Estimated value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",11.8,"E","Estimated value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",11.5,"E","Estimated value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",14.4,"E","Estimated value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",15.6,"E","Estimated value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",4.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",4.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",4.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",4.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",4.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",4.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",4.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",3.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",3.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",3.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",3.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",1.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",1.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",1.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",24.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",27,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",27.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",32.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",33.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",33.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",20.6,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",20,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",19.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",18.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",18.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",16.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",9.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",8.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",8.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",8.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",8.9,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",8.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",8.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",8.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",9.1,"B","Break"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",9.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",9.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",9.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",9,"P","Provisional value"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",2.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",2.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",2.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",3.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",3.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",3.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",3.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",4.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",4.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",2.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",2.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",3.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",3.3,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",3.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",3.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",3.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",3.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",3.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",3.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",4.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",4.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",15.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",14.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",14.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",14,"B; D","Break; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",13.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",13.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",13.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",13.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",13.7,"E; D","Estimated value; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",13.8,"E; D","Estimated value; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",14.7,"E; D","Estimated value; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",13.6,"E; D","Estimated value; Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",1.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",1.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",2.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",2.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",2.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",2.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",2.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",2.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",2.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",4.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",5.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",3.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",3.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",3.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",3.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",3.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",3.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",3.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",3.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",7.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",6.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",6.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",6.7,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",6.6,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",6.4,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",6.5,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",6.2,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",6.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",15,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",15.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",15,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",15.1,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",14.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",14.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",14.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",15,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",14.8,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",14.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",15,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",14.9,"D","Difference in methodology"
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",15,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",26.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",26.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",26.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",26.3,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",26.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",25.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",25.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",25.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",24.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",24.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",25.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",25.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",22,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",21.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",20.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",20.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",21.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",20.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",19.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",19.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",18.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",18.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",19.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",17,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",45.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",44,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",43.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",42,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",41.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",40.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",39.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",38.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",37.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",34.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",34.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",33.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",49.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",49.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",48,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",46.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",44.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",43.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",42.7,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",42,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",42.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",41.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",41.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",40.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",38.8,"D; P","Difference in methodology; Provisional value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",43.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",43.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",44.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",45.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",47.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",49,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",47.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",48.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",47.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",49.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",48,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",46.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",108.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",102.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",98.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",97,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",94,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",90.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",87.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",83.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",81.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",83.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",83.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",80.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",61.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",59.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",58.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",57.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",56.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",54.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",52.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",51.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",51.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",51.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",50.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",50.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",48.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",47.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",47,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",48.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",48.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",49,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",51.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",50,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",48.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",51.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",50.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",50.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",76.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",76.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",75.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",73.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",74.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",72.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",71.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",69.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",70.1,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",71.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",72.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",71.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",23.2,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",22.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",23.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",28.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",29.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",30,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",31.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",31.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",30.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",43,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",44.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",43,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",42.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",41.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",40.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",40.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",40.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",40.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",40.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",41.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",39.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",38.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",60.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",58.7,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",56.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",54.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",52.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",51.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",51.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",47.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",46.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",44.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",42.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",39.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",34.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",37.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",38.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",38.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",38.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",38.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",38.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",38.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",38.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",39.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",38.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",37.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",36.9,"E","Estimated value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",19.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",20.3,"B","Break"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",19,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",18.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",17.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",17.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",14.7,"B","Break"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",14.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",14.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",14.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",15.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",15.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",29.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",30.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",31.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",31.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",31.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",31.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",31.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",30.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",30,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",30.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",29.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",28.8,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",26.1,"D; P","Difference in methodology; Provisional value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",54,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",53.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",53.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",52.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",51.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",50.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",49.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",48.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",47.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",47.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",45.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",44.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",43.7,"E","Estimated value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",42.5,"E","Estimated value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",40.3,"E","Estimated value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",45.3,"E","Estimated value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",43.2,"E","Estimated value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",47.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",42.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",40.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",38.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",37,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",35.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",33.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",32,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",31.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",30.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",29.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",28.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",27.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",44.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",43.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",46.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",48.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",50.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",51.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",51.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",51.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",52.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",54.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",53.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",54.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",53.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",39.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",39.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",37.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",43.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",44.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",45.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",43.1,"B","Break"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",42.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",44,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",44.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",45.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",44.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",44.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",44.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",42.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",41.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",43.6,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",43.6,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",43.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",43.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",43.7,"B","Break"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",43.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",42.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",42.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",42,"P","Provisional value"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",84.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",81.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",77.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",74.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",70.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",67.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",65,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",61.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",59.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",57.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",56.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",54.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",53,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",6.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",6.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",6.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",7.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",7.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",7.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",8.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",9.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",9.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",10.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",10.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",65.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",63.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",61.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",60.3,"B; D","Break; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",58.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",55.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",53,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",50.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",48.8,"E; D","Estimated value; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",47.3,"E; D","Estimated value; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",45.9,"E; D","Estimated value; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",44.4,"E; D","Estimated value; Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",54.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",68.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",53,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",102.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",75,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",80.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",72.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",44.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",69.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",83,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",100.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",74,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",21.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",21.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",22.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",23.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",24.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",25,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",24.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",24.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",26.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",26.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",27.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",26.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",26.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",14.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",20.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",20.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",20.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",18.4,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",18.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",18,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",17.3,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",16.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",17.8,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",36.1,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",35.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",35.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",35.5,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",35.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",35.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",35.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",35.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",35,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",35.2,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",34.9,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",33.7,"D","Difference in methodology"
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",33.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",25.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",25.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",26,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",26.4,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",26.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",26,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",25.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",25.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",25.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",25.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",25.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",26,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",49.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",48.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",45.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",39.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",39.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",37.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",36.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",35,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",33.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",32.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",31.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",29.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",78.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",78.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",78.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",78,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",77.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",76.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",75.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",73.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",71.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",70.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",70.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",68.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",26.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",26.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",26.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",26.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",25.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",25.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",25.5,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",25.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",24.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",24.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",24.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",24.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",23.9,"D; P","Difference in methodology; Provisional value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",70.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",68.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",66.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",65.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",64.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",65.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",64.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",65,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",61.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",60.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",59,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",58.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",35.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",35.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",35.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",35.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",35.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",35.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",35.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",34.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",34.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",34.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",34.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",34.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",71,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",70.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",70.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",70.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",69.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",68.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",66.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",65.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",65.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",64.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",65.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",63.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",57.8,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",56.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",58.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",57.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",56.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",55.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",55.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",54.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",54.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",54.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",52.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",52.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",89.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",89.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",89.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",89,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",88.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",87.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",85.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",83.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",82.8,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",82.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",81.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",80.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",44.1,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",43,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",45.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",50.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",52.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",52.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",55.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",54.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",54.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",55.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",59.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",61.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",63.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",66.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",68.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",69.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",71.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",72.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",72.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",75.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",70.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",71.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",42.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",42.8,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",42,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",41.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",40.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",39.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",39,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",38.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",36.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",35.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",35.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",34.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",31.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",45.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",46.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",47.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",48.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",48.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",49.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",50.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",51.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",52.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",53.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",53.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",53.7,"E","Estimated value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",14.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",14.9,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",14.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",14.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",13.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",13.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",12.7,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",12.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",13,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",13,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",14,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",14.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",40.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",39.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",39.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",39.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",39.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",39.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",39.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",37.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",38.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",38.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",39.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",38.2,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",34.1,"D; P","Difference in methodology; Provisional value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",52.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",53.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",52.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",51.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",50.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",48.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",47.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",46.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",44.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",43.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",42.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",40.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",31.4,"E","Estimated value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",30.5,"E","Estimated value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",28.4,"E","Estimated value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",30.4,"E","Estimated value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",28.8,"E","Estimated value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",40.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",39.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",38.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",37.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",36.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",35.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",35.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",34.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",34.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",33.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",33,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",32.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",33.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",29,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",28.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",31.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",32.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",33.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",33.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",34.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",34.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",36.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",38,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",39.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",39.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",40.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",56.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",57.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",57.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",67.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",71,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",73.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",64,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",64.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",65.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",65.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",66.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",65.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",21.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",21.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",21.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",21.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",23.1,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",23.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",23.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",24,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",24.2,"B","Break"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",24.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",24.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",24.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",24.6,"P","Provisional value"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",54.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",53.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",52.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",52.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",51.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",50.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",49.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",48.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",47.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",47.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",46.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",45.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",45.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",13.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",15.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",16.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",16.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",17.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",18.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",19.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",20.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",22.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",24.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",26.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",27.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",30.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",29.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",29.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",30.3,"B; D","Break; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",30.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",29.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",29.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",29.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",29,"E; D","Estimated value; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",28.8,"E; D","Estimated value; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",28.8,"E; D","Estimated value; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",28.6,"E; D","Estimated value; Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",13.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",22.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",18.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",25.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",27.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",23.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",21.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",19.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",19.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",28.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",26.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",24.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",33.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",35.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",40.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",42.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",45.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",47.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",49,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",51.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",54.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",55.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",56.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",57,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",58.5,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",20.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",26.3,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",25.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",25.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",24.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",23.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",23.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",22.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",21.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",21.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",38.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",40.1,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",41.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",42.9,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",43.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",43.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",44.4,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",44.5,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",44.8,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",44.6,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",44.7,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",44.2,"D","Difference in methodology"
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",44.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",47.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",45.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",44.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",43.5,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",41.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",40.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",39.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",38.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",38,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",37.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",38.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",39.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",40.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",40.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",40.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",40.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",39.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",30.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",17.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",16.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",16.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",16.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",16.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",16,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",52.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",51.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",50.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",50,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",49,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",48.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",48,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",46.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",45.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",44.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",44.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",43.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",51.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",52.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",53.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",54.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",54.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",55,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",55.4,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",56.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",59.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",61.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",64.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",66.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",67,"D; P","Difference in methodology; Provisional value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",80.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",80.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",78.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",75.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",75.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",71.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",67.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",64.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",60.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",59.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",56.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",57,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",78.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",83,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",85.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",87.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",89,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",89.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",88.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",87.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",89.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",94.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",99.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",106.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",69.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",71.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",74.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",76.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",78.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",80.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",81.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",86,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",90.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",95.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",99.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",104.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",54.3,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",53.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",53.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",54.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",54.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",55.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",57.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",57.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",57.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",60.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",62.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",63.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",77.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",78.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",79.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",80.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",81.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",82.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",83.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",84,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",87,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",92.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",96.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",98.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",47.6,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",45.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",45,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",45.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",44.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",44.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",45.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",44.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",43.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",76.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",75.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",72.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",62.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",56.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",54.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",52.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",50.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",49.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",48.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",49.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",45.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",43.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",42.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",43.7,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",44.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",46.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",45.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",47,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",48.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",50.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",53,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",55.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",58.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",61.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",62.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",63,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",59.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",58.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",57.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",56,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",55.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",53.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",53.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",53.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",54,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",53.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",52.2,"E","Estimated value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",71.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",62.1,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",60.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",58.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",54,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",51.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",50.1,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",46.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",45.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",43.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",46.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",46.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",39.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",39.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",38.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",38.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",37.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",36.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",35.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",34,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",33.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",33.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",34.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",33.3,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",30.5,"D; P","Difference in methodology; Provisional value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",45.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",47.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",50,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",51.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",53.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",54.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",56.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",59.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",60.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",63.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",65.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",68,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",58.5,"E","Estimated value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",59.9,"E","Estimated value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",58.1,"E","Estimated value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",66.3,"E","Estimated value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",67,"E","Estimated value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",55.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",56,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",56,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",57.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",57.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",57.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",58.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",58,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",58.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",61.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",62.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",63.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",65.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",45.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",43.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",44.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",45.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",45.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",44.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",44.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",44.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",45,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",47.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",47.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",47.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",49.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",78,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",76.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",65.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",71.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",70.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",68.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",68,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",65.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",63.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",62.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",62.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",60.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",36.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",35.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",34.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",35,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",37.2,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",37.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",38.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",38.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",39.4,"B","Break"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",40.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",41.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",41.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",42.4,"P","Provisional value"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",65.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",68.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",71.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",75.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",77.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",79.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",82.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",84.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",87.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",91.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",94.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",98.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",104.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",21.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",23.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",23.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",24.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",23.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",25.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",24.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",25.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",26.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",26,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",29.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",29.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",76.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",76.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",79.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",80.5,"B; D","Break; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",82.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",83.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",85.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",87.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",90,"E; D","Estimated value; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",92.8,"E; D","Estimated value; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",95.4,"E; D","Estimated value; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",96.9,"E; D","Estimated value; Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",20,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",30.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",31,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",52.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",50.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",42,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",38.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",39.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",35.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",73.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",62.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",62.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",66.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",64.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",68.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",64.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",61.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",58.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",54.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",52,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",49.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",46.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",46.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",44,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",43,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",42.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",47.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",45.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",45.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",43.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",40.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",41.4,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",40.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",37.5,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",36.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",56.6,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",56.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",57.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",57.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",59.2,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",58.9,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",58.1,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",57.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",56,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",54.7,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",53.8,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",52.3,"D","Difference in methodology"
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",50.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",137.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",134.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",134.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",135.5,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",132.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",129.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",126.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",125.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",124.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",123.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",126.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",128.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",145.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",150,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",151.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",151.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",151.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",148.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",146.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",144,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",142.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",144.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",147.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",134.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",148.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",150.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",151.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",151.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",151.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",151.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",151.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",149,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",148.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",151.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",152.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",154.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",185.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",188.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",186.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",182.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",180.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",178.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",193.5,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",195.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",200.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",205.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",210.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",214.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",212.9,"D; P","Difference in methodology; Provisional value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",239.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",238.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",245.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",247.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",253.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",256.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",255,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",255.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",250.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",252.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",254.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",251.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",160.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",164.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",171.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",174.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",175.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",177.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",179.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",180.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",188.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",201,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",212.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",219.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",204.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",208.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",215.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",220.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",225.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",230,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",233.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",240.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",253,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",264.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",274.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",281,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",151.2,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",157.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",158.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",160.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",155.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",158.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",159.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",161.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",157.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",172,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",168,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",153,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",285.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",297.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",308.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",318.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",329.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",335.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",341.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",342.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",357.4,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",377,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",389.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",397.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",176.1,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",168.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",171,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",173.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",171.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",169.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",171.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",166.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",164.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",324,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",334.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",331.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",347.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",359,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",363.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",363.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",365.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",367.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",369.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",384.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",371.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",370.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",111.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",117.8,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",118.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",121.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",121.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",124.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",127.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",128.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",133.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",133.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",136.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",138.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",136.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",217.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",219.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",221.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",221.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",220,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",221.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",219.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",220.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",223.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",224.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",222.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",220.1,"E","Estimated value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",43.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",45.4,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",45.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",47.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",45.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",43.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",41.7,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",45.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",46.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",48,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",52.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",54.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",112.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",112.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",109.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",107.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",104.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",102.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",99.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",96.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",95.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",96.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",85.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",84,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",75.7,"D; P","Difference in methodology; Provisional value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",136.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",140.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",144,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",144.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",144.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",143.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",143.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",143.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",143.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",143.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",142,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",142.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",117.6,"E","Estimated value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",121.1,"E","Estimated value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",118.1,"E","Estimated value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",138.9,"E","Estimated value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",139.8,"E","Estimated value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",133.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",136,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",139.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",141.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",143.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",145.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",147.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",150.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",152.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",158.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",160.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",165,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",170.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",138.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",127.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",127.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",122.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",119.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",116.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",117.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",115.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",116.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",121.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",122.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",121.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",121.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",172.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",178.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",176.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",195.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",198,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",199.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",209.6,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",206.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",205.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",205.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",207.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",203.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",158.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",161.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",162,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",162.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",173.8,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",175.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",178.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",179.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",182.7,"B","Break"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",184.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",186.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",188.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",190.1,"P","Provisional value"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",146.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",152.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",157.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",164,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",168.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",173.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",177.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",179.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",182.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",188.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",194.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",198,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",205,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",68.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",71.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",73.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",74.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",75.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",77.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",78.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",82.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",87.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",90.9,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",99.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",98.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",185.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",188.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",193,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",195.1,"B; D","Break; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",197.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",197.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",197.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",197.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",197.8,"E; D","Estimated value; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",198.8,"E; D","Estimated value; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",199.1,"E; D","Estimated value; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",196.8,"E; D","Estimated value; Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",77.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",176,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",140.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",276.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",228.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",215.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",173.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",161.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",231,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",281.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",246.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",284.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",163.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",165.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",185.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",189.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",191.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",196.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",193.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",198.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",202.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",203.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",209.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",207.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",213.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",81,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",115.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",111.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",115.6,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",109.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",107.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",104.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",102.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",101.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",103.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",267.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",267.5,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",263.2,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",263.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",260.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",258.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",255.3,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",250.8,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",247.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",243.7,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",239.1,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",234.4,"D","Difference in methodology"
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",232.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",131.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",137.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",135.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",134.2,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",131.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",134,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",133.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",134.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",138.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",140.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",147.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",155.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",58.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",64,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",67.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",71,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",74.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",77.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",82.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",87.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",93.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",101.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",103.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",93.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",116.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",121.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",127.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",130.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",130.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",133.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",136.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",137.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",141.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",147.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",152.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",159.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",87.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",92.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",96.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",98.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",100.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",103.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",110.2,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",114.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",123.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",133.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",140.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",150.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",154.6,"D; P","Difference in methodology; Provisional value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",86.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",92,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",100.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",103.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",112.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",117.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",125.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",130.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",135.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",145.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",155.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",169.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",108.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",114.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",120,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",125.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",132.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",141.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",141.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",148.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",157.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",167.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",181.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",195.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",98.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",95.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",98.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",102.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",102.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",105.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",105.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",112.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",120.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",133.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",147.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",167.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",90.6,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",97.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",102.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",94.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",93.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",93.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",92.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",90.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",90.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",95.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",94,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",100.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",65,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",67.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",70.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",73,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",76.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",79.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",84,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",87.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",94.7,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",103.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",113.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",125.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",102.9,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",99,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",104.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",116,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",123.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",131,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",141.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",150.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",165.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",90.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",98,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",101.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",104.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",104.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",107.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",108.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",109,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",110.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",111.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",118.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",115.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",120,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",71.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",78.8,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",81.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",87.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",87,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",89.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",90.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",91.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",92.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",94.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",97.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",99.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",98.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",68.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",73.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",76.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",78.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",81.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",85,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",88.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",92.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",98,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",103.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",109.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",115.3,"E","Estimated value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",30.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",35,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",39.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",45,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",52.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",58.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",63.1,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",67.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",72.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",75.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",83.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",94,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",103.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",111.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",116.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",116.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",116.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",117.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",113.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",107.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",104.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",104.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",103.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",105,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",99.4,"D; P","Difference in methodology; Provisional value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",94.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",100.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",106.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",111.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",116.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",120.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",124.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",129.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",133.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",136.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",137.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",140.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",135.2,"E","Estimated value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",139,"E","Estimated value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",133.7,"E","Estimated value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",154.2,"E","Estimated value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",156.2,"E","Estimated value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",112.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",116.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",118.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",121,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",123.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",128.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",131.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",135.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",142.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",147.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",161.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",173.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",186.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",89.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",87.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",94,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",101.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",105.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",106.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",109.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",108.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",112.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",124.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",133.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",142.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",156.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",113.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",129.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",130.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",152.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",152.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",152,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",97.5,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",98.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",93.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",95,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",98.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",100.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",82.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",89.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",93.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",96.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",105.4,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",110.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",114.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",117.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",123.2,"B","Break"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",125.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",128.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",135.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",142.2,"P","Provisional value"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",75.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",77.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",79.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",85.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",92,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",99.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",106.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",115.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",124.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",134.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",144.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",155.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",172.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",27.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",30.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",25.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",18.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",18.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",18.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",19.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",21.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",23.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",25.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",33,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",36,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",127.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",129.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",134.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",134.7,"B; D","Break; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",136.4,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",139,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",141.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",149,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",156.2,"E; D","Estimated value; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",162,"E; D","Estimated value; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",168.6,"E; D","Estimated value; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",173.8,"E; D","Estimated value; Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",27.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",44.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",51.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",58.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",76.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",72.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",66.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",89.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",114,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",101.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",157.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",136.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",26.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",32,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",40,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",43.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",47.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",51.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",53.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",58.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",64.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",69.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",79.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",88.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",102.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",81.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",109.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",112.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",115.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",115,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",115,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",116.2,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",116,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",117.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",118.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",82.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",93,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",101.6,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",109.9,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",112.5,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",118.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",125.1,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",132.7,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",137.8,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",146.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",156,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",165.3,"D","Difference in methodology"
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",179.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",31.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",32.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",31.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",29.2,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",29.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",29.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",29.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",30,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",29.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",30.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",30,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",29.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",34.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",36.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",36.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",37.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",36.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",34.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",34.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",34,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",33.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",33.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",32.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",32.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",71.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",68.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",66.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",64.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",62.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",61.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",60.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",58,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",55.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",54.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",51.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",40.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",23.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",23.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",24.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",25.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",25.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",25.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",40.4,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",42.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",42.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",44,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",45.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",47.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",47.7,"D; P","Difference in methodology; Provisional value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",118.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",116.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",117.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",110.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",108.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",105.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",102.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",99.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",96.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",95,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",90.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",91.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",102.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",103.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",101.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",101.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",100.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",99.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",99.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",98.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",96.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",96.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",94.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",93.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",133.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",134.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",130.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",133.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",132.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",131.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",131.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",132.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",134.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",138.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",138.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",142.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",124.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",125.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",126.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",115.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",112.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",113.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",110.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",110.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",107.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",108.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",98.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",97.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",62.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",61,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",60.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",59.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",60.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",60.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",59.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",58,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",59,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",62.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",69.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",70.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",29.7,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",29.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",30.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",34.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",35.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",36.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",37.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",38.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",39.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",18.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",19,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",17.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",19.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",19.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",18.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",19.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",20,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",20.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",21.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",22.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",22.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",23.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",130,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",109.1,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",110.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",110.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",109.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",110.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",110.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",109.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",106.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",107.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",107.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",108.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",108.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",43.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",43.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",43.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",43.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",43.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",42.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",41.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",42.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",44.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",44.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",46.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",47.1,"E","Estimated value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",25.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",27.1,"B","Break"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",29.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",32.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",35.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",37.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",38.2,"B","Break"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",40.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",44,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",47.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",52.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",57.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",41.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",40,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",38.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",37.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",35.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",35.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",37.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",35.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",35.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",35,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",30.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",32.1,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",30.2,"D; P","Difference in methodology; Provisional value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",158.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",62.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",63.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",55.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",50.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",50.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",51.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",50.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",52.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",53.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",52.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",53,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",70.5,"E","Estimated value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",90.4,"E","Estimated value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",90.9,"E","Estimated value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",101.4,"E","Estimated value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",96.9,"E","Estimated value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",98.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",101.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",101,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",103.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",107,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",110.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",116.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",117.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",119,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",122.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",121.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",123.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",122.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",49.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",47.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",46.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",46.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",47.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",47.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",49.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",48.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",49.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",53.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",51.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",53.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",54.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",71,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",71.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",70.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",78.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",81,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",81,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",59.6,"B","Break"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",58.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",57.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",55.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",49.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",48.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",36.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",36.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",42,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",42.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",41.9,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",44.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",47,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",48.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",50.8,"B","Break"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",62.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",61.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",69,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",71.4,"P","Provisional value"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",101.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",100.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",99.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",99.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",102.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",102.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",103.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",104.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",107.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",112.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",112.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",113.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",117.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",44.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",49.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",50.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",50.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",53,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",56.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",53.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",68.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",69.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",73.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",74.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",80.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",41,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",41.5,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",43.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",46.5,"B; D","Break; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",47.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",48.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",49.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",51,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",52.8,"E; D","Estimated value; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",55.1,"E; D","Estimated value; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",50.3,"E; D","Estimated value; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",60.8,"E; D","Estimated value; Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",21.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",23.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",22.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",25.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",73.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",30.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",35.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",45.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",40.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",32.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",39.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",40.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",50.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",52.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",54.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",54.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",54.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",55.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",54.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",54.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",55.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",56.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",56.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",56.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",58.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",32.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",40.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",42.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",43.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",44.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",45.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",45.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",43.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",46,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",46.1,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",97,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",96.4,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",94.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",95.2,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",90.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",73.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",73.6,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",71.9,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",71.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",72.3,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",69.8,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",69.7,"D","Difference in methodology"
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",69.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",27.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",27.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",27.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",27.2,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",27.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",27.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",27.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",28,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",27.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",28.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",27.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",27.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",18,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",18,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",17.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",16.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",15,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",12.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",11.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",11.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",11.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",11,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",11,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",11.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",65.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",62.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",61.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",59.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",57.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",56.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",55.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",53.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",51.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",50.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",47.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",36.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",10.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",9.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",9.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",9.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",8.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",15.2,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",15.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",14.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",14.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",14.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",15.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",15,"D; P","Difference in methodology; Provisional value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",93,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",87.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",84.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",76.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",70.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",66.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",61.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",58,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",54.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",52.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",49.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",48.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",84.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",83.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",81.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",79.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",77.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",75.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",74.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",73.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",70.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",70.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",67.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",64.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",93.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",91.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",90.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",84.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",85.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",82.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",81.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",79.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",80.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",80.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",83.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",84.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",124.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",125.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",126.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",115.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",112.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",113.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",110.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",110.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",107.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",108.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",98.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",97.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",40.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",38.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",36.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",35.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",35.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",34.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",33,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",31.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",31.6,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",34.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",40,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",40,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",3.7,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",3.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",3.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",3.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",3.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",4.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",4.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",4.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",7.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",7.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",5.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",6.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",6.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",4.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",4.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",4.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",3.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",4.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",4.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",4.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",81.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",85.2,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",85.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",84.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",82.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",82.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",80.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",77.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",73.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",73.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",71.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",71.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",71.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",14.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",13.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",12.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",11,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",9.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",7.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",5.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",5.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",5.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",5.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",5.5,"E","Estimated value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",8.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",7.9,"B","Break"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",8.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",9.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",9.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",9.9,"B","Break"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",9.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",9.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",10.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",10.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",12.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",17.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",16.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",16.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",16,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",14.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",13.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",13.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",13.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",13.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",12.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",9.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",10.9,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",10.3,"D; P","Difference in methodology; Provisional value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",107,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",36.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",36.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",32.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",27.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",26.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",27.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",26.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",26.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",27.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",26.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",25.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",59.6,"E","Estimated value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",78.5,"E","Estimated value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",79,"E","Estimated value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",89.1,"E","Estimated value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",85.3,"E","Estimated value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",77,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",77.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",76.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",77.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",79.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",82.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",87,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",87.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",87.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",88.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",87.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",87.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",85.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",16.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",15.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",15.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",15.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",15.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",15.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",16.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",16.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",16.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",16.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",15.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",16.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",16.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",43.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",41.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",37.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",38,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",30.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",28.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",23.7,"B","Break"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",22.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",22.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",21.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",18.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",20.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",10.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",10.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",16.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",16.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",13.4,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",14.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",16.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",17.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",18.5,"B","Break"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",19.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",19.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",21.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",22.8,"P","Provisional value"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",80.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",78.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",76.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",75.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",76.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",74.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",73.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",73.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",74.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",77.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",76.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",76.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",79.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",23.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",25,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",24.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",22.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",24.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",25.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",24.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",36.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",35.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",35.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",34.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",40.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",21.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",20.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",21,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",21.4,"B; D","Break; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",20.8,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",20.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",20.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",20.6,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",21.3,"E; D","Estimated value; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",22.5,"E; D","Estimated value; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",18.3,"E; D","Estimated value; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",27.5,"E; D","Estimated value; Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",19.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",19.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",19.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",21.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",64.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",16.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",14.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",11.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",29.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",18.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",24.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",26.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",36.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",36.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",37.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",35.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",35.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",34.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",33.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",31.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",31.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",32.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",30.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",30.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",31,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",16.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",17.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",17,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",17.7,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",18,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",18.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",18.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",16.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",19,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",19.2,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",53.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",51,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",47.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",44.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",39.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",36.4,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",34.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",32.3,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",31.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",30.9,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",29.1,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",28.5,"D","Difference in methodology"
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",27.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",33,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",34,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",36.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",38,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",39.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",40.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",41.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",41.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",41,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",41.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",39.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",39.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",39.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",38.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",39.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",39.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",35,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",34.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",34.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",34.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",34.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",33.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",33.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",32.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",39,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",40.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",41.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",42.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",43.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",43.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",44.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",43.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",44.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",44.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",43.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",43.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",37,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",38.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",39.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",40.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",40.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",41.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",45.2,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",45.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",44.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",44.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",43.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",43.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",41.9,"D; P","Difference in methodology; Provisional value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",42.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",43,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",45.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",46.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",49.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",51.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",53.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",55,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",53.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",54.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",55.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",56.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",31.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",32,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",32.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",33.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",34.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",34.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",35.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",35.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",36.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",37,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",37.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",37.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",48.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",47.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",50.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",51.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",53.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",54.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",55.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",54,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",56.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",56.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",56,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",55.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",66.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",64.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",72.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",72.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",72,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",74.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",75.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",76.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",74.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",77.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",64.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",71.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",76.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",78.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",80.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",82.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",85.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",86.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",86.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",86.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",88.1,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",89,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",89.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",88.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",16,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",15.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",16.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",20.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",22.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",24,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",25,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",29.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",30.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",16.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",17.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",17.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",18.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",20.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",21.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",22.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",23.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",24.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",25.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",26.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",27.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",27,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",38,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",36.9,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",38.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",40.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",41.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",43.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",44.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",44.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",44.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",44.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",44.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",44.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",42.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",37.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",38.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",39.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",39.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",39.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",39.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",39.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",40.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",41.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",41.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",41.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",43.5,"E","Estimated value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",25.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",35,"B","Break"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",37.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",42.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",42.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",40.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",32.9,"B","Break"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",33.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",33.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",35.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",34.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",35.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",46.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",48,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",49.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",50.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",51.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",52.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",53.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",53.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",54.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",55.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",43.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",43.2,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",39.4,"D; P","Difference in methodology; Provisional value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",25.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",26.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",27.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",27.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",28.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",29.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",30.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",30.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",30.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",30.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",29.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",29.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",33,"E","Estimated value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",32.9,"E","Estimated value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",31.3,"E","Estimated value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",33.1,"E","Estimated value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",32.4,"E","Estimated value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",45.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",45.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",46.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",47,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",47.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",47.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",48.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",48.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",49.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",49.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",48.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",48.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",49.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",27,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",27.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",29.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",30.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",31.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",33.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",34.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",36.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",38.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",39.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",38.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",40.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",43.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",31.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",31.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",29.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",36.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",47.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",51.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",38.5,"B","Break"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",39,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",38.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",35.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",29.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",32,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",26.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",27.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",28.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",28.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",32.5,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",35,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",37.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",39.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",46,"B","Break"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",48,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",46.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",50.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",54.7,"P","Provisional value"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",42.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",42.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",43.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",43.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",44.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",44.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",45.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",45,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",45.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",45.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",44.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",44.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",44.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",14.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",16.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",19.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",17.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",20.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",19.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",21.3,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",21.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",24.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",25.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",27.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",30,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",31.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",31.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",32.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",33.3,"B; D","Break; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",33.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",33.9,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",34.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",36.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",43.5,"E; D","Estimated value; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",44,"E; D","Estimated value; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",43.7,"E; D","Estimated value; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",44.1,"E; D","Estimated value; Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",19.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",34.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",29.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",36.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",35.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",33.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",47.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",42.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",43.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",63.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",63.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",68.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",19,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",19.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",21.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",23.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",24.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",25.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",26.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",28.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",29.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",29.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",30.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",31.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",32.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",25.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",30.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",31.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",32.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",31.7,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",31.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",31.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",30.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",31.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",32.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",18.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",19.8,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",20.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",21.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",22.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",23.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",24.1,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",25.5,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",26.6,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",27.2,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",28.4,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",29,"D","Difference in methodology"
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",29.7,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",25.2,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",26.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",25.3,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",20.6,"B; D","Break; Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",21,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",21,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",20.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",20.2,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",19.5,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",19.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",16.4,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",16.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",14.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",10.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",11.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",28,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",28.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",28.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",27.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",27,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",27.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",27.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",26.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",25.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",25,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",19.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",20.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",15.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",16.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",16.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",16.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",16.5,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",16.5,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",18.9,"B; D","Break; Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",18.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",18.3,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",16.2,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",13.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",12.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",12.9,"D; P","Difference in methodology; Provisional value"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",18.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",15.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",16,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",20.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",21.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",20.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",20.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",20.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",20.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",20.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",19.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",19.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",18.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",17.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",17.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",21,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",23.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",22.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",21.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",20.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",19.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",17.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",17.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",16.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",13.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",13.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",29.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",29.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",30.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",30.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",29.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",29.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",29.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",28.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",29.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",30.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",25.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",26.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2010","2010",39.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2011","2011",37,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2012","2012",33.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",34.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",34.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",38.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2016","2016",40.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",34.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",37.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",39.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",33.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",28.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",27.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",16.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",16.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",15.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",15.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",16.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",17.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",15.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",15.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",16.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",15.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",12.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",13.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",21.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",21.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",21.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",21.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",22.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",19.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",19.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2010","2010",19.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2011","2011",20.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2012","2012",21.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2013","2013",21.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2014","2014",21.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2015","2015",23.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2016","2016",22.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2017","2017",21,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2018","2018",22.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2019","2019",22.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2020","2020",18.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2021","2021",17.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2010","2010",28.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",29.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",28.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",29.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",27.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",27.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",27.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",24.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",24.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",24.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",21.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",19.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",34.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",36.9,"B","Break"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",37.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",38.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",40.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",39.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",39,"B","Break"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",37.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",38.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",34.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",29.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",28.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",29,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",29.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",29,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",28.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",27.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",27.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",26.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",26.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",25.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",25.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",20.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",10.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",11,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",10.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",10.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",10.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",10.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",10.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",9.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",9.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",9.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",8.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",8.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",30.4,"E","Estimated value"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",29.9,"E","Estimated value"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",26,"E","Estimated value"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",24.7,"E","Estimated value"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",24.4,"E","Estimated value"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",18.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",19,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",19.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",18.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",18.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",18.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",18.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",17.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",17.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",17.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",16.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",16.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2014","2014",23.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2015","2015",27.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2016","2016",28,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2017","2017",29.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2018","2018",28.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2019","2019",27.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2020","2020",23.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2021","2021",24,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",24.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",25.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",25.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",23.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",23.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",24.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",26.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",25.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",24.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",26.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",22.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",22.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",22.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",20.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",24.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",22.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",27.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",26.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",21.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",23.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",20.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",16,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",19.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",28.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",27.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",27.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",24.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",19.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",17.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",17.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",17.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",16.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",16.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",15.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",15.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",15,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",14.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",14.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",12.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",12.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",40.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",43.5,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",43.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",42.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",41,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",41.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",42.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",37.3,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",33.3,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",34.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",27.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",29.6,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",20.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",22.5,"E; D","Estimated value; Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",21.9,"E; D","Estimated value; Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",19.8,"E; D","Estimated value; Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",19.7,"E; D","Estimated value; Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",15.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",19.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",19.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",21.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",19.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",16.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",27.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",26.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",32.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",38.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",14,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",15.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",15.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",15.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",15.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",17.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",17.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",18.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",18.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",19,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",16.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",16.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",16.4,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",24.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",27.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",26.9,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",24.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",20.7,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",20.8,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",16.7,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",16.1,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",18.2,"D","Difference in methodology"
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",14.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",14.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",14.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",14.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",14,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",14.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",13.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",14,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",14,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",13.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",11.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",11.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",24.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",24.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",23.7,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",18.5,"B; D","Break; Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",18.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",18.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",18.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",17.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",17.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",17.6,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",14.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",14.6,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",11.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",8.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",8.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",24.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",25.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",25.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",24.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",24,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",24.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",24.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",22.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",22.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",21.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",16.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",17.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",14,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",14.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",15.4,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",15.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",14.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",14.8,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",16.7,"B; D","Break; Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",16.4,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",16.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",13.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",11.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",10.4,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",10.6,"D; P","Difference in methodology; Provisional value"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",16.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",13.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",13.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",17.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",18.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",17.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",17.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",17.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",17.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",17,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",16.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",15.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",15.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",14.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",14.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",21.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",20.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",19.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",19.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",18.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",17.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",15.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",15.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",14.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",11.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",11.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",25,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",25.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",25.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",24.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",25.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",25.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",24.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",25.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",20.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",21.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2010","2010",35.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2011","2011",33.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2012","2012",29.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",29.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",31,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",33.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2016","2016",33.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",34.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",34.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",34.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",28.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",23.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",14.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",14.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",14.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",14.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",15.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",15.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",14.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",14.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",14.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",14.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",11.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",12,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",19.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",19.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",19.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",20.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",20.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",19.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",16.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",16.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2010","2010",19,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2011","2011",20.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2012","2012",21,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2013","2013",21.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2014","2014",21,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2015","2015",23,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2016","2016",22,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2017","2017",21,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2018","2018",22.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2019","2019",22.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2020","2020",18.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","IRL","Ireland","2021","2021",17.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2010","2010",24.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",24.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",25.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",24.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",24.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",24,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",20.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",21.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",21.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",18.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",17.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2011","2011",13.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2012","2012",14,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2013","2013",13.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2014","2014",14,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2015","2015",14.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2016","2016",14.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2017","2017",13.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2018","2018",13.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2019","2019",13.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","JPN","Japan","2020","2020",10.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",27.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",29.1,"B","Break"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",29.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",30.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",31.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",31.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",30.3,"B","Break"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",29,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",29.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",26.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",21,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",19.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",25.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",25,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",25,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",23.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",23.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",22.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",22.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",22.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",21.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",16.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",15.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",10.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",11,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",10.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",10.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",10.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",10.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",10.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",9.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",9.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",9.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",8.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",8.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",28.4,"E","Estimated value"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",27.7,"E","Estimated value"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",23.8,"E","Estimated value"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",22,"E","Estimated value"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",21.6,"E","Estimated value"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",16.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",17.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",17.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",17.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",16.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",16.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",16.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",15.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",15.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",14.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",13.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",14,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2014","2014",21.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2015","2015",24.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2016","2016",22,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2017","2017",25.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2018","2018",24.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2019","2019",23.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2020","2020",18.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","POL","Poland","2021","2021",20.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",19.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",20.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",20.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",17.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",18,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",18.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",19,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",18.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",19.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",19.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",15.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",15.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",21.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",23.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",21.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",24.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",23.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",20,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",22,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",19.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",14.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",16,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",27.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",26.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",26.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",24.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",19.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",20,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",15.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",15.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",15.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",14.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",14,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",13.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",13.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",12.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",12.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",11.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",10.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",10.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",39.7,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",42.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",42.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",41.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",39.5,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",40.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",40.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",35.3,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",31,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",31.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",24.4,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",27,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",20.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",20.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",20.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",19.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",18.6,"E; B; D","Estimated value; Break; Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",18.2,"E; D","Estimated value; Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",16.2,"E; D","Estimated value; Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",16.4,"E; D","Estimated value; Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",11.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",17.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",16.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",17.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",18.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",15.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",14.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",16.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",23.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",24.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",30.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",36.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",11.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",12.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",12.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",12,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",11.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",12.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",12,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",11.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",11.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",11.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",10.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",10.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",15.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",22.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",24.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",23.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",21.2,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",18.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",19.1,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",13.4,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",14.5,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",16.5,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",13.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",13.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",13.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",13.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",13.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",13.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",13,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",13.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",13.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",13,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",10.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",10.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",40.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",61.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",66.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",41.4,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",42.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",43.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",44.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",46,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",48.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",49.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",51.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",52.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",57.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",55.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",56.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",55,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",54.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",52.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",51.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",49.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",45.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",44.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",42.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",42.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",61.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",61.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",62.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",62.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",63.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",64.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",64.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",63,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",62.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",60.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",55.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",56.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",35.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",34.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",31.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",30,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",30.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",27.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",38.3,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",36.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",35.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",35.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",34.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",35.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",34.8,"D; P","Difference in methodology; Provisional value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",77.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",77.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",78.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",78.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",81.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",82,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",82.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",82.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",84.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",83,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",84.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",83.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",72.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",75.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",66,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",65.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",64.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",65.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",64.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",61.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",59.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",59.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",58.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",56.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",105.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",103.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",104.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",106.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",103.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",101.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",100.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",100.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",98.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",99.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",101.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",99.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",50.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",48.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",49.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",45.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",44.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",40,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",38,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",35.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",34,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",32.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",22.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",28,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",70.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",70.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",71,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",71.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",71.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",71.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",70.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",68.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",66,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",66.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",64,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",65.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",41.5,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",38.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",38,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",38.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",40,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",38.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",39.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",44.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",46.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",60,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",58.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",57.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",58.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",61,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",61.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",62.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",62.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",62.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",63.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",62.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",59.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",58,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",89.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",58.9,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",55.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",53,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",51.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",52.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",53.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",54.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",52.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",52.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",57.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",61.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",59.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",46.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",44.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",44.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",44.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",43.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",42.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",41.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",42,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",42.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",41.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",43.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",45.2,"E","Estimated value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",56.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",60.3,"B","Break"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",62.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",65.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",68.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",71.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",67.5,"B","Break"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",69.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",73.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",78.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",82.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",88.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",76.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",75.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",75.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",77,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",77.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",75,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",75.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",72.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",70.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",68.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",51.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",50.6,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",46.1,"D; P","Difference in methodology; Provisional value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",39.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",39.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",39.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",41,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",42.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",42.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",41.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",41.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",40.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",39.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",34.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",33.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",54.9,"E","Estimated value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",56.3,"E","Estimated value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",55.3,"E","Estimated value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",61,"E","Estimated value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",61.1,"E","Estimated value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",59.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",60.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",62,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",62.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",61.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",62.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",62.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",63.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",62.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",63.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",65,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",67.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",68.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",105.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",100.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",101.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",101.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",99,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",98.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",97.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",94,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",94.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",93.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",84.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",83.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",88.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",140.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",138.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",131,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",139.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",145,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",143.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",71.5,"B","Break"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",73,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",73,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",70.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",70.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",73.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",87.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",85.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",76.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",70.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",70.1,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",65.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",64.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",62.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",68.4,"B","Break"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",70.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",67.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",71.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",77.3,"P","Provisional value"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",67.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",67.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",67.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",66.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",65.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",67.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",70.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",71.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",70.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",72.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",68.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",70.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",73.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",56.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",59.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",63.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",56.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",59.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",61.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",64.7,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",62,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",61.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",64.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",58.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",65.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",50.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",49.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",49.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",49.8,"B; D","Break; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",49.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",48,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",46.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",43.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",44,"E; D","Estimated value; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",43.3,"E; D","Estimated value; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",44,"E; D","Estimated value; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",42.8,"E; D","Estimated value; Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",22.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",31.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",32.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",36.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",41.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",37.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",34.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",39,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",42.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",61.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",73,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",75.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",59.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",62.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",69,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",72.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",75.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",78.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",78.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",79.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",79.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",83.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",84.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",84.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",91.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",22,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",27.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",27.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",27.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",28.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",28,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",28.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",26.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",27.1,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",26.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",61.6,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",62.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",60,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",57.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",57.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",61,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",60.4,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",61.5,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",64.3,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",65.9,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",63.2,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",65.8,"D","Difference in methodology"
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",70.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",23.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",22.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",22.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",22.7,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",22.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",22,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",21.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",20.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",20.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",19.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",19.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",18.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",39.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",38.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",38.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",37.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",35.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",34.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",33.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",31.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",27.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",26.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",25.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",25.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",38.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",39.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",39.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",37.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",37.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",37.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",37.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",35.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",34.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",33.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",28.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",29.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",21.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",20.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",18.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",17.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",18.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",15.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",21,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",19.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",18.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",17.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",16,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",15.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",15.3,"D; P","Difference in methodology; Provisional value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",57,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",57.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",58.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",57.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",58.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",57.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",58.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",57.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",58.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",56,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",58.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",56.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",53.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",54.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",44.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",42.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",40.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",40.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",38.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",36,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",34,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",33.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",31.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",31.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",84.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",86.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",87.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",83.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",81.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",80,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",80.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",78.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",79.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",80.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",77.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",78.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",50.8,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",48.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",49.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",45.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",44.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",40,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",38,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",35.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",34,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",32.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",22.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",28,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",39.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",39.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",40,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",40.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",40.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",39.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",39,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",36.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",36.8,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",36.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",34.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",35.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",12,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",10.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",10.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",9.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",8.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",7.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",8.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",8.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",27.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",25.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",24.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",24.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",26.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",26.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",26.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",26.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",26.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",27.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",27,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",26.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",25.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",75.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",45.1,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",42.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",39.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",38.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",38.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",39.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",39.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",38.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",39.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",41.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",44.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",44.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",25.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",23.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",23.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",22.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",21.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",19.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",19.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",18.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",18.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",16.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",17.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",19,"E","Estimated value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",37.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",39.8,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",41,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",42.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",46.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",49,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",45.5,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",46.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",49.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",50.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",51.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",52.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",50.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",51.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",50.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",50.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",49.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",48.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",47.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",45.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",44.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",43.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",26.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",26.9,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",24.7,"D; P","Difference in methodology; Provisional value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",22.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",22.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",22.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",21.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",20.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",20.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",19.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",19.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",18.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",18.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",16.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",16.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",33.6,"E","Estimated value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",34.3,"E","Estimated value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",33.5,"E","Estimated value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",36.1,"E","Estimated value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",36.3,"E","Estimated value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",45.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",46.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",47.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",47,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",46.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",47.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",47.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",48.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",47.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",48,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",49.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",51.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",52.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",74,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",70.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",71.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",73.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",73,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",73.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",73.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",70.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",71.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",70.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",62,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",60.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",65.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",63.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",57.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",53.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",60.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",62.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",60.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",44.2,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",43,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",42.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",39.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",38.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",41.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",59.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",58.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",52.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",49.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",49.7,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",45.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",44.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",42.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",42.4,"B","Break"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",44.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",41.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",45.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",51,"P","Provisional value"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",54.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",54,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",54.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",53.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",52.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",54.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",56.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",56.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",55.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",56.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",52.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",53.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",56.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",47.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",51,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",54.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",47.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",51.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",53.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",55.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",52,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",51.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",54.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",48.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",53.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",29.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",28.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",27.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",28.6,"B; D","Break; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",27.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",27.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",26,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",24,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",22.7,"E; D","Estimated value; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",21.8,"E; D","Estimated value; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",20.8,"E; D","Estimated value; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",21.6,"E; D","Estimated value; Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",20,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",28.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",30.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",33.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",39,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",35.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",32.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",36.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",38.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",56.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",67.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",71.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",51.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",55.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",60.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",63.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",66.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",68,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",67.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",67.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",66.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",68.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",69.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",68.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",73.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",10.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",12.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",12,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",12.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",13.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",13.1,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",12.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",11.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",11.9,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",11.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",42,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",41.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",40.2,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",39.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",41,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",44.5,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",43.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",43.7,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",45.8,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",46.3,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",43.6,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",45.4,"D","Difference in methodology"
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",48.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",170.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",184.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",187,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",189,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",196.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",203.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",180.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",181.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",185,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",187.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",194.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",200,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",120.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",126,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",128.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",130.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",133.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",132.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",132.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",133.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",135,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",136.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",138.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",137.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",123.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",128,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",130.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",133.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",137.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",142.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",146.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",147.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",148.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",153,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",155.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",159.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",153.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",161.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",164.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",165.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",167.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",170,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",211.1,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",212.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",217,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",222.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",227.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",239.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",243.5,"D; P","Difference in methodology; Provisional value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",143.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",145.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",146.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",151,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",159.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",166.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",170,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",176,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",176.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",182.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",186.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",189.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",270.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",274,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",275.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",268.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",260.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",264.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",265.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",264.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",264.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",269.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",275.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",291.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",260.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",261.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",261.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",260,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",258.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",252.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",249.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",260.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",270.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",279,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",289.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",311.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",260.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",246.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",244.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",244.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",243,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",241.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",238.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",234.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",228.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",220.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",217.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",229.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",121.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",125.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",128.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",129.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",133.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",135.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",136.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",136,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",139.4,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",143.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",146.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",149.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",122.3,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",121.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",128.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",143.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",149.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",157.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",172,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",177.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",181.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",118.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",123.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",120.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",126.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",124.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",125.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",125.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",125.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",124.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",123.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",125.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",119.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",118.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",327.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",286.3,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",288.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",300.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",300.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",314.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",329.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",335.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",331.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",338.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",361.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",387.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",385.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",81.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",82.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",84.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",84.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",85.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",86.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",86.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",89.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",92.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",94.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",95.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",98,"E","Estimated value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",70.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",84,"B","Break"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",88.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",96.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",101.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",105.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",96,"B","Break"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",100.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",105.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",114.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",129.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",141.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",215.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",216,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",214.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",214.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",215.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",210.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",208.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",202.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",197.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",197.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",172.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",171.9,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",156.5,"D; P","Difference in methodology; Provisional value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",98,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",102.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",105.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",103.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",106,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",109.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",111.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",113.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",115.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",109.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",110.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",110.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",231.4,"E","Estimated value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",231.6,"E","Estimated value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",233.7,"E","Estimated value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",242.2,"E","Estimated value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",250.6,"E","Estimated value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",230.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",233.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",233.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",235.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",237.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",239.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",241.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",243.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",242.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",251.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",256.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",267.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",280.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",277.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",277.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",292.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",299.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",306.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",312.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",317.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",321.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",326.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",344.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",351.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",362.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",381.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",163.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",165.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",160.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",185.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",196.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",204.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",163.8,"B","Break"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",163.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",168.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",173,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",176.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",175.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",226.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",232.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",231.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",234.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",254.7,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",269.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",269.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",274.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",300.2,"B","Break"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",309.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",322.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",339.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",349.9,"P","Provisional value"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",269.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",276.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",279.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",286.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",287.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",293.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",299,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",304.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",303.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",314.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",324.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",324.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",335.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",68.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",77.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",79.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",79.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",86.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",91.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",93.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",98.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",101.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",101.5,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",108.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",113,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",152.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",159.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",166.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",186.6,"B; D","Break; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",194.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",201.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",208.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",216.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",226,"E; D","Estimated value; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",232.6,"E; D","Estimated value; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",236.9,"E; D","Estimated value; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",247.6,"E; D","Estimated value; Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",89.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",123.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",126.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",123.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",136.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",120,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",111.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",112.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",146.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",196,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",233.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",201.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",86,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",91.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",99,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",103.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",108.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",113.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",117.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",123.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",127.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",134.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",141.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",148.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",160.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",90.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",121.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",125.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",131.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",139,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",143.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",148.8,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",148.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",155,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",165.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",127.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",134.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",135,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",140.2,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",142.6,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",145.4,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",148.3,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",150,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",152.1,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",154,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",154.7,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",158.9,"D","Difference in methodology"
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",165.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",34.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",38.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",40.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",42.4,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",43.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",45.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",18.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",17.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",17.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",16.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",16,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",15.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",10.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",10.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",11.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",11.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",11.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",12.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",12.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",12.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",13.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",14.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",15,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",14.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",16.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",18,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",19.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",21,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",22.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",23.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",26,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",27.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",28,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",29.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",29.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",31.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",9.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",9.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",9.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",9.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",9.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",9.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",14.8,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",13.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",13.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",13.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",14.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",15.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",15.4,"D; P","Difference in methodology; Provisional value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",21.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",24.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",23.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",25,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",26.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",28.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",29.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",31.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",32.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",33,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",36.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",35.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",97.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",97.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",97.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",95.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",90.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",94.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",96.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",96.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",95.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",95.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",95.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",98.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",47.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",49.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",51.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",51.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",54.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",52.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",53.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",55.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",55.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",56.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",59.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",58.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",104.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",97.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",94.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",95.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",97,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",99.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",95.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",97.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",93.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",83.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",84.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",88.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",23.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",23.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",24.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",24.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",24.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",25,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",25.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",25.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",26.5,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",27.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",27.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",34.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",4.3,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",4.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",5.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",1.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",1.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",1.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",1.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",1.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",6.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",6.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",6.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",6.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",6.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",6.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",6.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",7.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",8.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",8.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",8.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",8.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",8.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",54.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",32.8,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",32.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",34.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",34.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",35.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",37.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",37.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",34.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",34.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",35.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",37.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",50.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",5.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",5.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",6.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",6.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",6.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",7.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",8.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",8.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",9.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",9.8,"E","Estimated value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",11.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",11.7,"B","Break"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",12.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",12.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",13.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",13.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",11.9,"B","Break"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",11.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",12.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",12.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",12.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",14.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",30,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",31.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",32.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",33.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",33,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",33.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",33.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",32.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",33,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",31.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",29.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",30.1,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",28.2,"D; P","Difference in methodology; Provisional value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",13.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",14.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",16.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",12.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",13,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",14.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",14.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",15.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",16.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",9.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",9.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",9.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",49.5,"E","Estimated value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",46.2,"E","Estimated value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",48.5,"E","Estimated value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",43.8,"E","Estimated value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",47.1,"E","Estimated value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",62,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",64,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",65.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",66.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",68.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",69.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",71.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",73.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",75.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",78.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",80.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",85.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",91.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",22.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",22.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",23.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",23.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",24.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",25.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",25.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",25.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",25.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",27.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",30.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",31.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",36.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",30.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",32.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",32.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",38.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",40,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",42.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",21.2,"B","Break"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",20.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",20.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",19.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",21.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",20.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",36.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",36.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",35.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",37,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",40.7,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",43.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",46.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",49.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",53,"B","Break"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",56.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",60.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",65,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",70.6,"P","Provisional value"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",75.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",74.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",74.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",76.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",75,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",74.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",74.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",73.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",74.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",75.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",77.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",76.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",79.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",6.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",7.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",7.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",8.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",10.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",9.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",10.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",10.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",10,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",10,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",11.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",13.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",32.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",34.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",35.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",43.4,"B; D","Break; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",44.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",43.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",43.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",41.7,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",38.9,"E; D","Estimated value; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",37.6,"E; D","Estimated value; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",37.2,"E; D","Estimated value; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",36.7,"E; D","Estimated value; Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",14.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",22.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",28.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",16.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",27.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",30,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",23.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",20.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",32.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",38.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",52,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",30.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",13,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",13.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",14.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",16.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",17.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",18.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",20.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",23,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",25.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",27.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",31.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",33,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",39.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",6.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",7.9,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",8.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",10.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",12.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",12.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",10.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",14.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",15.4,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",14.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",18.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",19.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",19.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",20.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",21.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",23.3,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",24.6,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",26.2,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",26.8,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",27.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",28.1,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",29.5,"D","Difference in methodology"
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",32.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",15.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",15.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",13.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",11.4,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",10.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",9.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",9.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",8.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",7.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",6.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",6.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",7.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",8.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",8.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",8.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",7.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",7.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",7.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",7.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",6.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",6.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",12.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",12.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",12,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",11.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",10.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",10,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",10.3,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",9.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",8.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",7.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",7.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",6.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",6.1,"D; P","Difference in methodology; Provisional value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",15.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",14.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",13.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",12.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",12.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",12.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",12,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",11.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",11.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",11.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",11,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",10.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",11.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",10.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",10.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",9.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",7.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",6.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",6.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",5.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",5.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",4.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",27.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",26.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",25.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",24.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",23,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",21.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",20,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",18.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",17.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",16.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",15.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",14.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",53,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",51,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",50.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",49.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",49.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",47.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",46.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",45.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",44.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",42.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",42.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",47,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",4.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",4.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",4.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",4.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",3.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",3.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",3.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",3.4,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",3.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",3.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",3.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",23.4,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",22.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",23.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",25.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",25.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",27.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",32.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",32.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",32.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",24.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",26.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",26.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",28.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",28.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",28.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",27.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",27.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",26.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",25.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",25.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",23.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",22.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",24.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",22.8,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",21.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",21.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",21.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",21,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",20.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",20.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",19.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",18.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",18.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",19,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",17.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",1.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",2.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",2.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",2.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",1.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",2.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",2.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",2.1,"E","Estimated value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",13.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",14.9,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",14.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",14.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",13.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",13.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",12.4,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",11.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",12.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",12.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",14.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",41.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",40.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",38.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",36.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",36.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",35.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",33.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",32.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",31.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",30.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",19.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",18.5,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",16.3,"D; P","Difference in methodology; Provisional value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",6.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",6.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",6.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",6.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",6.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",6.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",7.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",7.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",7.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",7.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",6.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",3.9,"E","Estimated value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",4,"E","Estimated value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",4,"E","Estimated value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",4,"E","Estimated value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",4,"E","Estimated value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",19.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",18.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",17.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",16.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",16,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",14.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",13.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",12.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",12,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",12,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",11.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",11.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",92.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",93,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",96.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",97.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",97.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",97.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",95.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",93.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",92.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",89.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",84.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",85.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",85,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",22.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",22.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",21.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",24,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",25.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",24.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",22.1,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",21.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",22.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",23.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",24.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",25.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",51.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",52,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",51.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",52.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",56.4,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",56.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",56.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",56.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",56.8,"B","Break"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",56.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",58.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",60.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",59.5,"P","Provisional value"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",16.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",16.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",15.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",15.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",15,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",14.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",13.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",12.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",11.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",11.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",10.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",10,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",9.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",2.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",2.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",2.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",2.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",2.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",2.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",1.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",1.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",2.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",2.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",5.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",4.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",5.8,"B; D","Break; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",5.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",5.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",5.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",5,"E; D","Estimated value; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",4.8,"E; D","Estimated value; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",4.7,"E; D","Estimated value; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",4.5,"E; D","Estimated value; Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",11.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",12.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",10.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",11.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",11.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",10.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",5.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",7.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",4.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",13.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",13.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",14.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",14.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",14.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",13.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",12.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",13,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",13.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",13,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",13.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",7.1,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",7.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",7.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",7.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",7.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",7.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",7.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",7.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",18.8,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",18.5,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",17.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",17.2,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",16.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",15.4,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",14.6,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",13.9,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",13,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",12.3,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",12,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",11.7,"D","Difference in methodology"
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",11.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",7.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",7.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",6.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",4.7,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",4.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",4.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",3.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",3.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",3.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",3.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",2.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",2.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",5.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",5.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",5.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",4.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",5.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",4.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",4.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",4.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",3.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",3.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",3.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",3.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",11.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",12.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",12.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",11.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",11.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",11.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",23.1,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",21.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",20.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",19.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",19,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",18.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",17,"D; P","Difference in methodology; Provisional value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",16.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",16.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",17.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",18,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",19.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",20.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",20.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",20.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",20.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",21.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",21,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",20.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",20.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",20.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",20.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",19.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",20,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",20,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",19.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",19,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",18.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",18.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",19.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",22.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",49,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",47.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",44.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",42.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",39,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",35.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",31.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",32.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",40.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",44.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",46.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",49.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",50.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",47.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",47.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",46.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",44.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",43.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",44.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",40.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",38.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",39.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",35.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",37,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",6.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",5.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",5.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",5.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",5.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",4.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",4.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",3.4,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",3.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",3.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",3.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",5.3,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",5.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",5.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",6.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",6.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",7.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",9.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",8.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",7.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",0.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",73.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",72.3,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",70,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",69.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",66.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",65.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",65.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",64.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",62.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",61.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",66.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",73.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",72.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",0.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",1.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",1.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",1.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",1.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",1.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",1.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",1,"E","Estimated value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",7.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",8.1,"B","Break"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",8.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",9.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",10.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",10.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",10,"B","Break"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",10.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",11,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",11.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",13.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",14.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",54.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",52.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",51.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",50.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",49.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",48.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",47.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",45.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",42,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",41.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",37.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",35.5,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",31,"D; P","Difference in methodology; Provisional value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",4.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",5.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",5.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",5.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",5.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",5.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",5.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",5.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",5.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",5.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",5.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",17.4,"E","Estimated value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",17.6,"E","Estimated value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",17.8,"E","Estimated value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",18.2,"E","Estimated value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",18.7,"E","Estimated value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",47.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",47.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",45.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",46,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",46.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",45.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",45.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",45.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",44.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",46.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",46.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",49.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",51.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",17.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",17.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",18.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",18.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",18.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",17.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",17.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",16.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",16.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",16.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",16.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",16.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",16.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",14.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",15.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",14.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",17.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",18,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",18.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",14.4,"B","Break"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",14.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",14.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",14.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",15.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",10.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",26.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",27.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",28,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",28.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",30.6,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",30.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",31.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",31.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",32.5,"B","Break"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",32.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",34.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",35.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",35.2,"P","Provisional value"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",53.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",54.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",54.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",54.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",53.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",52.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",54.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",58.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",60.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",66,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",70.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",67.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",67.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",0,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",11.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",11.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",10.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",11.1,"B; D","Break; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",10.9,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",10.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",10.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",10.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",11.1,"E; D","Estimated value; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",11,"E; D","Estimated value; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",11.5,"E; D","Estimated value; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",11.3,"E; D","Estimated value; Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",4.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",5.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",7.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",7.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",10.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",7.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",8.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",9.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",23.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",36.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",31.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",34.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",14.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",16.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",17.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",18.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",19.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",20.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",20.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",21,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",20.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",21,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",22.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",22.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",22.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",15.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",20.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",21,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",21.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",22.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",23,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",23.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",24.2,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",23.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",24.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",14.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",14,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",13.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",13.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",12.4,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",11.7,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",11.1,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",10.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",10.3,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",9.8,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",9.6,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",9.5,"D","Difference in methodology"
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",9.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",80.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",88.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",91.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",96.2,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",100.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",104.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",106.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",109.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",112.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",115.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",122.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",127.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",54.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",57.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",58.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",59.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",60.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",60.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",60.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",61,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",61.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",62,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",63.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",63.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",68.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",70,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",70.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",72.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",74.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",77.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",79,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",78.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",79.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",81.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",83.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",86.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",78.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",82.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",83.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",85,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",87.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",90.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",100.1,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",104.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",108.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",114.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",122,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",130.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",134,"D; P","Difference in methodology; Provisional value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",41.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",44.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",46.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",49,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",52.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",55,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",57.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",59.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",61.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",64.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",65.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",69.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",84,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",85.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",83.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",80,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",76.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",77,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",76.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",75.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",76.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",78.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",80.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",84.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",69.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",70.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",69.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",69.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",68.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",68.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",67.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",70.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",74.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",78.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",81.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",85.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",53.4,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",51.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",52,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",51.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",51.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",51.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",51.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",51.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",51.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",54.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",54.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",57.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",46.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",50,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",51.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",53.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",55.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",56.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",56.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",56.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",58.5,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",60.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",62.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",64,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",44.7,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",44.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",48.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",55.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",58,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",61,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",65.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",70.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",73.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",26.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",27.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",26.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",27.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",27.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",28.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",28.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",28.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",29.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",29.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",30.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",29.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",30.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",101.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",103.8,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",106.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",113.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",115.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",125.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",133,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",138.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",142,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",146,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",153.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",161.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",157.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",38.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",38.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",39,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",39.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",39.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",39.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",40.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",41.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",42.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",43.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",44.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",45.5,"E","Estimated value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",11.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",13.8,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",15.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",17,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",18,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",20.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",17.2,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",18.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",21,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",23.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",27.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",31.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",50.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",51.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",52,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",53.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",56,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",53.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",54.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",53,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",52.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",54.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",55.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",57.3,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",53.1,"D; P","Difference in methodology; Provisional value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",40.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",41.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",42.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",43.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",44.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",45.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",45.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",46.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",47.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",48,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",48.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",48.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",81.4,"E","Estimated value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",82.6,"E","Estimated value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",81.4,"E","Estimated value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",92,"E","Estimated value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",96,"E","Estimated value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",56.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",57.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",57.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",56.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",57.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",58,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",57.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",57.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",56.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",57.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",58.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",61.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",63.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",78.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",78.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",84.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",87.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",92.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",95.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",99.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",103.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",109.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",123.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",131,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",138.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",150.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",29,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",30.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",30.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",35.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",38.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",40,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",38.9,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",39.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",41.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",42.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",42.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",44.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",61.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",63.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",64,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",65.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",71.3,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",73.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",75.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",77.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",80.4,"B","Break"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",83.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",86.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",92.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",98.4,"P","Provisional value"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",75.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",79.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",81.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",84.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",87.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",92.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",95,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",96.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",98.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",102.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",105.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",108.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",114.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",32.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",37,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",37.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",36.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",38.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",40.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",41,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",43.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",44.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",44.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",48.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",52.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",65.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",70.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",75,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",82.3,"B; D","Break; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",87.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",94.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",100.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",107.9,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",116.5,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",123.9,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",131.7,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",138.2,"E; D","Estimated value; Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",25.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",42.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",41.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",43.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",46.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",36.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",42,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",40.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",52,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",67,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",90.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",94.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",15.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",17.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",20.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",21.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",23.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",24.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",27.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",28.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",31.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",34.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",37,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",40.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",44.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",34.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",42.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",44.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",46.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",49.2,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",51.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",53.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",55.4,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",57.7,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",61.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",47,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",50,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",51,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",53.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",55,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",56.8,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",58.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",59.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",61.5,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",63.3,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",63.6,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",66.1,"D","Difference in methodology"
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",68.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",43.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",43.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",41.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",38.2,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",38.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",37.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",36.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",35.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",33.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",32.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",33.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",29.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",48.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",48.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",47.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",46.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",43.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",42.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",42.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",41.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",40.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",38.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",37,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",35.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",104.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",108.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",108.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",110.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",111.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",106.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",112.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",108,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",113.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",105.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",104.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",106.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",33,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",33.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",33.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",33.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",34.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",34.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",53.7,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",51.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",52.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",53.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",53.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",52,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",54,"D; P","Difference in methodology; Provisional value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",134,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",138.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",131.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",134.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",138.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",147,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",148.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",151.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",154.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",154.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",148,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",157.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",125.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",127.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",128.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",129.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",132.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",133.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",138.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",142.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",147,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",153.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",154.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",162,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",148.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",149.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",149.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",154.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",168.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",166.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",172.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",175.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",183.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",189.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",194.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",198.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",65.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",67.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",69.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",67.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",68.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",69,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",68.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",68.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",68.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",68,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",67.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",69.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",69.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",70,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",68.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",70.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",71,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",70.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",70.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",68.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",71.6,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",72.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",70.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",71,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",70.7,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",69.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",76.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",74.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",72,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",72.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",68.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",65.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",81.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",63.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",65.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",62.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",63.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",63.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",64.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",65.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",65.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",66.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",66.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",66.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",63.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",65.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",117.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",89.2,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",90.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",88.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",88,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",91.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",94.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",96.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",94.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",94.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",95.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",97.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",102.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",47.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",46,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",46.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",46.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",45.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",44.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",43.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",43.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",44.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",44.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",41.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",42.8,"E","Estimated value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",81,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",73.7,"B","Break"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",76.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",82.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",84.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",85.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",84.6,"B","Break"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",82.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",86.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",95.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",79.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",75.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",71.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",71.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",70.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",74,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",74.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",72.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",74.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",69.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",72.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",71.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",67.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",64.7,"B; D; P","Break; Difference in methodology; Provisional value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",64.6,"D; P","Difference in methodology; Provisional value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",101.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",105.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",106.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",106.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",107.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",108.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",110.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",111.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",111.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",111.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",113.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",109.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",114.5,"E","Estimated value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",116.6,"E","Estimated value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",117.9,"E","Estimated value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",120.9,"E","Estimated value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",121.9,"E","Estimated value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",184.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",185.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",188.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",188.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",196.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",200.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",205.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",214.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",218,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",231,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",232.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",246.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",255.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",81.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",83.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",87.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",88,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",89.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",94.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",98.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",94,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",97.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",100.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",90.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",83.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",98.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",193.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",189.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",164.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",193.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",195,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",206.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",132,"B","Break"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",129.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",127.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",125.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",117.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",123.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",91.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",93.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",82.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",73.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",79.6,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",87.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",86.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",88.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",96.3,"B","Break"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",100,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",98.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",100,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",110.9,"P","Provisional value"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",152.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",154.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",161.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",162.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",170.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",173.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",181.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",190,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",194.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",206.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",216.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",221.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",231.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",75.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",87.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",77.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",82.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",87.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",94.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",96.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",99.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",109,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",111.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",97.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",98.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",134.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",137.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",145.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",150.1,"B; D","Break; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",156.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",158.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",165.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",160.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",114.4,"E; D","Estimated value; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",108.6,"E; D","Estimated value; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",108.9,"E; D","Estimated value; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",102.4,"E; D","Estimated value; Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",27.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",39.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",39,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",43.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",48.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",44.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",47.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",48.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",63.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",96.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",90.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",82.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",61.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",64.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",71.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",75.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",80,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",83.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",85.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",88.4,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",93.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",93.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",91.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",96.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",112.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",42.7,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",50.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",61.1,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",57.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",60.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",60.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",67.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",54.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",58.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",61.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",64.5,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",65.8,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",64.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",67.4,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",69.3,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",71.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",73.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",73.2,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",74.9,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",76,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",74.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",74.6,"D","Difference in methodology"
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",79.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2010","2010",38.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2011","2011",38.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2012","2012",37.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2013","2013",37.4,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2014","2014",37.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2015","2015",36.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2016","2016",35.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2017","2017",35.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2018","2018",33,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2019","2019",31.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2020","2020",33.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUS","Australia","2021","2021",29.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2010","2010",31.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2011","2011",31.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2012","2012",31.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2013","2013",31.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2014","2014",30.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2015","2015",29.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2016","2016",28.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2017","2017",28.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2018","2018",28,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2019","2019",27,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2020","2020",26.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","AUT","Austria","2021","2021",25.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2010","2010",53.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2011","2011",54.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2012","2012",54.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2013","2013",54.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2014","2014",54.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2015","2015",54.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2016","2016",54.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2017","2017",53.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2018","2018",54.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2019","2019",54.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2020","2020",52.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BEL","Belgium","2021","2021",52.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2010","2010",27.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2011","2011",27.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2012","2012",27.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2013","2013",28,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2014","2014",28.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2015","2015",28.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2016","2016",35.5,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2017","2017",34.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2018","2018",34.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2019","2019",33.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2020","2020",33.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2021","2021",33.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CAN","Canada","2022","2022",34.3,"D; P","Difference in methodology; Provisional value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2010","2010",46.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2011","2011",45.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2012","2012",45.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2013","2013",46.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2014","2014",48.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2015","2015",50.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2016","2016",51.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2017","2017",52.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2018","2018",52.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2019","2019",53.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2020","2020",54.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CZE","Czechia","2021","2021",57.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2010","2010",60.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2011","2011",60.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2012","2012",59.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2013","2013",58.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2014","2014",58.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2015","2015",59.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2016","2016",59.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2017","2017",60.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2018","2018",60.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2019","2019",61.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2020","2020",63.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DNK","Denmark","2021","2021",62.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2010","2010",63.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2011","2011",64.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2012","2012",66.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2013","2013",67.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2014","2014",71.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2015","2015",72.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2016","2016",74.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2017","2017",76.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2018","2018",78.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2019","2019",79.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2020","2020",83.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FIN","Finland","2021","2021",81,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2010","2010",65.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2011","2011",67.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2012","2012",69.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2013","2013",67.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2014","2014",68.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2015","2015",69,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2016","2016",68.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2017","2017",68.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2018","2018",68.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2019","2019",68,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2020","2020",67.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","FRA","France","2021","2021",69.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2010","2010",49.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2011","2011",49.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2012","2012",49.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2013","2013",50.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2014","2014",51,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2015","2015",49.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2016","2016",50,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2017","2017",49.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2018","2018",51.6,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2019","2019",53,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2020","2020",53.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","DEU","Germany","2021","2021",53.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2013","2013",50,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2014","2014",50.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2015","2015",53.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2017","2017",48.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2018","2018",48.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2019","2019",48.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2020","2020",47.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2021","2021",44.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GRC","Greece","2022","2022",54.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2010","2010",37.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2011","2011",39.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2012","2012",38.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2013","2013",41,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2014","2014",42,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2015","2015",42.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2016","2016",42.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2017","2017",42.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2018","2018",42.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2019","2019",41.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2020","2020",43.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2021","2021",41.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HUN","Hungary","2022","2022",41.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2010","2010",41.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2011","2011",43.7,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2012","2012",42.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2013","2013",42.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2014","2014",40.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2015","2015",40.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2016","2016",40.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2017","2017",40,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2018","2018",38.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2019","2019",37.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2020","2020",35,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2021","2021",34.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISL","Iceland","2022","2022",37.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2011","2011",35.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2012","2012",34.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2013","2013",34.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2014","2014",34.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2015","2015",34.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2016","2016",34.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2017","2017",33.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2018","2018",33.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2019","2019",34.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2020","2020",33.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2021","2021",31,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ITA","Italy","2022","2022",30.9,"E","Estimated value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2010","2010",19.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2011","2011",10.3,"B","Break"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2012","2012",12.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2013","2013",14.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2014","2014",14.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2015","2015",15.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2016","2016",14.3,"B","Break"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2017","2017",12.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2018","2018",13.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2019","2019",13.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2020","2020",12.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","KOR","Korea","2021","2021",12.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2010","2010",23.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2011","2011",24.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2012","2012",24.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2013","2013",25.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2014","2014",24.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2015","2015",23.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2016","2016",23.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2017","2017",21.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2018","2018",21.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2019","2019",20.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2020","2020",19,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2021","2021",17.2,"B; D; P","Break; Difference in methodology; Provisional value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LUX","Luxembourg","2022","2022",16.4,"D; P","Difference in methodology; Provisional value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2010","2010",59,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2011","2011",60.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2012","2012",61.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2013","2013",60.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2014","2014",60.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2015","2015",60.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2016","2016",60.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2017","2017",60.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2018","2018",59.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2019","2019",58.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2020","2020",59.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NLD","Netherlands","2021","2021",55.3,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2018","2018",46.5,"E","Estimated value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2019","2019",45.4,"E","Estimated value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2020","2020",45.3,"E","Estimated value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2021","2021",40,"E","Estimated value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NZL","New Zealand","2022","2022",41.2,"E","Estimated value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2010","2010",63.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2011","2011",64.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2012","2012",63.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2013","2013",63.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2014","2014",64.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2015","2015",65.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2016","2016",66.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2017","2017",67.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2018","2018",67.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2019","2019",68.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2020","2020",68.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2021","2021",67.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","NOR","Norway","2022","2022",68.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2010","2010",30.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2011","2011",31.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2012","2012",33.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2013","2013",33.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2014","2014",34,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2015","2015",33.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2016","2016",34.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2017","2017",32.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2018","2018",31.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2019","2019",31.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2020","2020",31.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2021","2021",29.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","PRT","Portugal","2022","2022",29.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2010","2010",33.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2011","2011",34.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2012","2012",34.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2013","2013",40.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2014","2014",41.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2015","2015",43.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2016","2016",35.2,"B","Break"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2017","2017",33.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2018","2018",31,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2019","2019",29.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2020","2020",29,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVK","Slovak Republic","2021","2021",30.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2010","2010",44.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2011","2011",46,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2012","2012",44.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2013","2013",45.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2014","2014",47.4,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2015","2015",53.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2016","2016",50.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2017","2017",51.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2018","2018",57.7,"B","Break"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2019","2019",58.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2020","2020",57.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2021","2021",56.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ESP","Spain","2022","2022",60.1,"P","Provisional value"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2010","2010",50,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2011","2011",50.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2012","2012",49.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2013","2013",50.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2014","2014",52.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2015","2015",53.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2016","2016",55,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2017","2017",55.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2018","2018",55.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2019","2019",57.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2020","2020",61.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2021","2021",58.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SWE","Sweden","2022","2022",60.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2010","2010",22.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2011","2011",24.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2012","2012",24.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2013","2013",29,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2014","2014",32.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2015","2015",37.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2016","2016",38,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2017","2017",40.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2018","2018",43.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2019","2019",44.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2020","2020",48.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","TUR","Türkiye","2021","2021",44.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2010","2010",87.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2011","2011",87.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2012","2012",90.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2013","2013",92.8,"B; D","Break; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2014","2014",95,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2015","2015",94.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2016","2016",97.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2017","2017",91.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2018","2018",65.6,"E; D","Estimated value; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2019","2019",62,"E; D","Estimated value; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2020","2020",61.1,"E; D","Estimated value; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","GBR","United Kingdom","2021","2021",56.4,"E; D","Estimated value; Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2011","2011",8.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2012","2012",10.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2013","2013",13.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2014","2014",13.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2015","2015",16.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2016","2016",16,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2017","2017",15.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2018","2018",15.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2019","2019",19.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2020","2020",36.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2021","2021",31.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CHL","Chile","2022","2022",41.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2010","2010",17.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2011","2011",18.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2012","2012",20.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2013","2013",22.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2014","2014",23.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2015","2015",24.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2016","2016",24.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2017","2017",25.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2018","2018",27.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2019","2019",27.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2020","2020",28,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2021","2021",27.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","EST","Estonia","2022","2022",28.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2012","2012",27.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2014","2014",20.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2015","2015",28.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2016","2016",25.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2017","2017",26.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2018","2018",26.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2019","2019",27.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2020","2020",23.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2021","2021",24.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ISR","Israel","2022","2022",24.9,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2010","2010",36.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2011","2011",36.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2012","2012",37.1,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2013","2013",38.5,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2014","2014",39.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2015","2015",41,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2016","2016",42.2,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2017","2017",42.4,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2018","2018",42.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2019","2019",43.7,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2020","2020",43.6,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2021","2021",42.8,"D","Difference in methodology"
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","SVN","Slovenia","2022","2022",43.9,"D","Difference in methodology"
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",14.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",15.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",15.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",17.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",15.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",15.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",16.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",16.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",16.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",16.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",14.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",13.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2010","2010",12.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2011","2011",12.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",12.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",13.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",12.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",13.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",12.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",14,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",13.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",13.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",11.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",11.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",160.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",169.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",182.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",202.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",224.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",259.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",294.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",304.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",360.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",387,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",400.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",28.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",30.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",33.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",37.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",40.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",42,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",43.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",46.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",52.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",54.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",55.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",40.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",41.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",42.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",43.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",43.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",45.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",46.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",48.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",50.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",50,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",51.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",79,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",82.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",82.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",84.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",85.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",88.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",88.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",90.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",92.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",107.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",102.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",255.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",272.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",279.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",282.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",283.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",297.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",298.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",310.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",333.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",333.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",336.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",4.6,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",4.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",3.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",3.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",3.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",2.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",2.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",2.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",2.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",2.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",2.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",2.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",2.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",2.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",2.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",2.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",3.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",7.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",8.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",9.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",9.8,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",10.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",11.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",12,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",13.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",16,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",15.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",16.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",18.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",19.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",19.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",18.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",18.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",18.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",18.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",19,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",19.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",19.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",19.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",40.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",43.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",46.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",48.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",49.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",52.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",52.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",56,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",60.8,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",60.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",60.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",37.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",37.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",37,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",35.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",33.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",33.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",31.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",31.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",33.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",31.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",31,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",79.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",80.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",79.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",77.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",74.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",74.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",71,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",70.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",72.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",69.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",68.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",41.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",51.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",56.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",62.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",67.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",79.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",84.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",92.1,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",101.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",108.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",112,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",11.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",11.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",12.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",12.7,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",13,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",13.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",13.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",14.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",15.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",16.2,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",18,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",5.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",5.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",5.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",5.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",5.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",4.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",4.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",4.4,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",4.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",5.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",20.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",22.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",24,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",24.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",25.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",27.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",27.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",29.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",31.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",32.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",34.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2010","2010",14.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2011","2011",31.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",14.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",15.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",15,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",16,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",16.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",17.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",16.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",18.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",15.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",14.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",66.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",68.2,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",71.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",73.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",74.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",75,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",75.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",77.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",79.5,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",82.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",91.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",56.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",58.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",61.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",62.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",62.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",62.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",62.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",63,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",63.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",65.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",73.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",77.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",81.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",84.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",88.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",92.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",97.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",98.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",104.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",112.3,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",115.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",121.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",5.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",5.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",5.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",6.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",6.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",6.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",6.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",6.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",7.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",8.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",12.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",13.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",14,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",14.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",15,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",15.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",15,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",15.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",16.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",16,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",16,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",5.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",5.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",6.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",7.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",8.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",8.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",9.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",10.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",11.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",12.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",9.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",10.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",11.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",12.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",13.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",15,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",16.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",17.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",19.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",21.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",24.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",48.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",48.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",50.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",49.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",47.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",50.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",50.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",50.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",46.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",48.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",62.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2012","2012",9.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2013","2013",8.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2014","2014",9.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2015","2015",7.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2016","2016",7.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2017","2017",7.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2018","2018",6.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2019","2019",6.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2020","2020",6.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2021","2021",5.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LVA","Latvia","2022","2022",6.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",184.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",191.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",214,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",217.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",220.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",214.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",213.8,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",220.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",218.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",231.3,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",239.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",231.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",18.3,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",17.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",19.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",20.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",21.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",21.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",21.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",22.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",23.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",26.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",29.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",28.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",59.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",66.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",69.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",72.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",71.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",68,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",69.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",74.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",76.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",80.3,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",86.6,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",85.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",14.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",13.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",14.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",14.6,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",12.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",12.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",12.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",10.1,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",10.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",9.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",14,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",12.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",19.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",20.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",23.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",24.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",25.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",27.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",29.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",32.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",31.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",35.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",36.8,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",37.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",30.1,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",32.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",37,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",40.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",43.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",44.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",47.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",50,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",53.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",56.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",59,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",58.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",4.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",4.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",3.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",3.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",3.2,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",2.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",2.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",1.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",0.1,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",0.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",0.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",0.7,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",0.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",0.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",0.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",0.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",0.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",0.2,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",0.3,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",0.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",19,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",18.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",20.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",24.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",24.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",23.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",22.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",22.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",21.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",21.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",21.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",19.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",53.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",59.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",69.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",72.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",78.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",80.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",83.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",88.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",89.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",89.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",100.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",102.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",28.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",27.4,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",30.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",29.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",30.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",29.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",31,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",30.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",31.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",35.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",36.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",35.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",36.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",36.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",37.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",36.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",36.1,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",32.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",28.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",27.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",26.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",27.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",27.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",26.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",53.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",60,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",62.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",65.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",64.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",60.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",61.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",64.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",65.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",66.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",70.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",69.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",15.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",16.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",16.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",19,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",16.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",17.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",18.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",18.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",18.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",18.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",16.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",15.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",5.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",6.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",7.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",6.9,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",7.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",8.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",9.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",9.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",10.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",11.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",12,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",11.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",118.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",123.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",136.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",140.9,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",149.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",153.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",155.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",155.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",153.6,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",161.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",169.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",160.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",17.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",16.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",16.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",16.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",16.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",15.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",15.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",15.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",14,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",14.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",16.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",15.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",20.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",21.9,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",25.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",28.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",29.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",29.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",26.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",26.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",23.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",26.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",24.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",25,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",357.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",373.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",425.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",438.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",451.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",439.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",439.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",454.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",457.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",492.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",519.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",520.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",25.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",26.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",31.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",33.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",36.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",39,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",41.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",43.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",44.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",46.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",54.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",52,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",27.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",30.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",34.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",23,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",25.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",26.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",27.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",30.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",31.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",32.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",34.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",32.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",9.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",13.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",15.3,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",19.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",21.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",29.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",37.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",46.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",58.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",75.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",92.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",5.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",2.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",6.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",6.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",6.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",6.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",6.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",7.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",7.1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",7.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",8.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",7.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",46.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",51.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",60.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",65.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",71.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",71.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",73.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",75,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",74.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",77.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",80.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",76.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",55.9,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",57.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",63.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",69.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",67.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",70.5,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",69.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",70.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",73.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",74.7,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",69,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",68.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",36.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",37.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",40.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",41.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",41.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",41,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",40.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",37.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",33.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",32.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",29.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",25,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2010","2010",98.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2011","2011",103.4,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2012","2012",113.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2013","2013",96.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2014","2014",103.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2015","2015",126,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2016","2016",125.9,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2017","2017",129.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2018","2018",138.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2019","2019",156.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2020","2020",186.8,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","LTU","Lithuania","2021","2021",192.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",45.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",46.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",47.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",53.9,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",58.2,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",53.5,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",55,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",56.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",58.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",63.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",66.6,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",72.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",59.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",250.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",261.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",273.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",307.2,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",324.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",294.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",301.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",309,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",324.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",339.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",356.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",369.9,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",267.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",21.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",24.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",26.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",29.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",29.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",28.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",29.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",30.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",33.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",35.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",39,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",41.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",34.5,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",47.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",47.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",50,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",57.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",60.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",54.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",54.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",54.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",56.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",57.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",60.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",61.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",49.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",104.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",111,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",115.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",129.5,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",138,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",126.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",130.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",135.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",144.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",153,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",164,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",171.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",107.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",24.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",23.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",24.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",25.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",27.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",22.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",22.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",21.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",20.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",20.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",13,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",13.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",14.3,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",6.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",7.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",7.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",6.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",6.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",6.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",6.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",7.1,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",7.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",6.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",28,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",27.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",29.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",32.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",33.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",31,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",32,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",32.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",33,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",35,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",33.3,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",35.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",27.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",32.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",34.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",36.7,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",41.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",43.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",40.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",44.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",47.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",51.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",55,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",56.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",60.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",47.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",15.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",14.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",14.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",16.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",17,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",15.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",16.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",16.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",17.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",19.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",19.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",22.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",17.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",45.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",48,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",50.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",57,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",61.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",57.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",59.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",62.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",66.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",72.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",78.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",82.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",67.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",1.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",1.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",1.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",1.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",1.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",1.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",0.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",0.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",0.8,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",0.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",0.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",33.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",31.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",32.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",36.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",38.5,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",34.2,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",35.4,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",36.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",37.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",38.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",50.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",54.1,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",45.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",0.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",0.5,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",0.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",0.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",37,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",39.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",41.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",46.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",49.5,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",44.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",44.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",44.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",46.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",48.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",50.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",52.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",43.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",1.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",1.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",1.7,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",2.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",2.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",2.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",2.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",2.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",2.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",2.2,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",0.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",1,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",0.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",0.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",0.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",0.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",146.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",126.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",127.9,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",136.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",138.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",126.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",126.5,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",128.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",136.6,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",145.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",145.2,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",156.3,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",126.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",24.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",25,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",25.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",27.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",27.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",24.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",23.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",22.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",21.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",21.3,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",21.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",20.7,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",17,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",28.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",29,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",30,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",31.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",31.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",26.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",26.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",25.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",24.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",24,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",16.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",16.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",16.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",9.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",8.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",8.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",9.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",9.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",8.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",8.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",8.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",9.9,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",9.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",9.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2010","2010",22.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2011","2011",23.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2012","2012",22,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2013","2013",24.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2014","2014",25.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2015","2015",23.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2016","2016",23,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2017","2017",22.5,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2018","2018",22.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2019","2019",23.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2020","2020",21.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2021","2021",24.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","CRI","Costa Rica","2022","2022",20.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",18.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",18.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",19.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",20.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",20.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",19.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",19.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",20,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",20.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",16.8,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",19.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2010","2010",19.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2011","2011",20.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2012","2012",19.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2013","2013",21.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2014","2014",22.3,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2015","2015",22.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2016","2016",21.5,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2017","2017",23.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2018","2018",24.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2019","2019",23.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2020","2020",26.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2021","2021",26.9,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2011","2011",28.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2012","2012",28.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2013","2013",29.4,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2014","2014",29.1,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2015","2015",30.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2016","2016",28.7,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2017","2017",28.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2018","2018",29.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2019","2019",30.2,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2020","2020",29.6,,
"PHARINFC","J-Antiinfectives for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2021","2021",29.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",18.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",18.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",20,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",19.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",19.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",19.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",18.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",18.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",18.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",18.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",15.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",18.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2010","2010",17.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2011","2011",18.3,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2012","2012",17.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2013","2013",18.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2014","2014",20,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2015","2015",20.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2016","2016",19.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2017","2017",20.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2018","2018",21.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2019","2019",20.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2020","2020",22.7,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","BGR","Bulgaria","2021","2021",24.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2011","2011",26.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2012","2012",25.9,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2013","2013",26.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2014","2014",26.6,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2015","2015",28.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2016","2016",24.4,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2017","2017",24.5,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2018","2018",25.1,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2019","2019",25.8,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2020","2020",25.2,,
"PHARBIOT","J01-Antibacterials for systemic use","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","ROU","Romania","2021","2021",25.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",42.4,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",40.7,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",41.6,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",43.2,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",44.8,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",48.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",51.3,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",54.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",61,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",65.1,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",67.9,,
"PHARFLAM","M01A-Antiinflammatory and antirheumatic products non-steroids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",56.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",36.6,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",38.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",37.5,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",37.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",25.1,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",26,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",26.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",28.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",31.8,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",36.3,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",36.9,,
"PHARGENU","G-Genito urinary system and sex hormones","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",38.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",63.4,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",65.7,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",68.3,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",71.2,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",72.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",74.5,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",76.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",75.8,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",78.6,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",79.1,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",81,,
"PHARANXO","N05B-Anxiolytics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",83.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",4.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",4.3,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",3.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",3.5,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",3.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",3.1,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",2.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",2.7,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",2.4,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",1.9,,
"PHARGLYC","C01A-Cardiac glycosides","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",1.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",49.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",58.7,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",59.4,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",62.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",63.3,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",64.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",67.6,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",66.9,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",69.2,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",77.8,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",79.5,,
"PHARDIAB","A10-Drugs used in diabetes","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",75.5,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",113.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",135.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",127.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",134.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",137.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",144.6,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",171.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",177.2,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",195.1,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",218.7,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",234.3,,
"PHARALIM","A-Alimentary tract and metabolism","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",263,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",51.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",51.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",51.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",54.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",54.1,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",57.8,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",59.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",62.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",70.6,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",78.3,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",74.2,,
"PHARRESS","R-Respiratory system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",73.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",39.9,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",40.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",42,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",44.8,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",45.6,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",47.4,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",49.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",50.2,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",49.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",49.7,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",51.1,,
"PHARDIUR","C03-Diuretics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",51.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",83.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",48.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",8.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",8.9,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",5.2,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",5.7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",4.8,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",5.5,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",7,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",6.6,,
"PHARSHMG","G03-Sex hormones and modulators of the genital system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",7.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",94.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",100.4,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",106.6,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",108.2,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",113,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",111.1,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",111.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",110.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",103.9,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",206.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",211.7,,
"PHARARAS","C09-Agents acting on the Renin-Angiotensin system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",221,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",148.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",148.2,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",148.4,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",155.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",158.8,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",165.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",171.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",172.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",179.1,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",195.5,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",202.7,,
"PHARCNSY","N-Nervous system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",208.6,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",0,,
"PHARACID","A02A-Antacids","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",0,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",7.9,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",7.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",7.6,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",7.5,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",8.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",7.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",7.3,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",6.8,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",6.7,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",6.4,,
"PHARARIT","C01B-Antiarrhythmics, Class I and III","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",6.4,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",16.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",11.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",9.8,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",11.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",13.2,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",13.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",15.1,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",15.7,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",16.3,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",16.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",17.6,,
"PHARHYPN","N05C-Hypnotics and sedatives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",19.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",112.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",78.1,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",98.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",97.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",102.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",100,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",98.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",100.4,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",100.8,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",99.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",101.7,,
"PHARBLOO","B-Blood and blood forming organs","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",116,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",20.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",20.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",20.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",21.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",21.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",22.8,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",23.7,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",22.3,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",22.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",31.6,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",27.9,,
"PHAROBAI","R03-Drugs for obstructive airway diseases","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",26.6,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",21.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",23.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",24.9,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",27.1,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",26.5,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",29.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",29.7,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",28.8,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",32.4,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",35.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",38.2,,
"PHARHORM","H-Systemic hormonal preparations, excluding sex hormones and insulins","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",43.2,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",39.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",29.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",32.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",33.9,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",34.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",36.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",39,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",39.6,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",45.1,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",46,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",47.4,,
"PHARBETA","C07-Beta blocking agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",48.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",83.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",48.6,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",52.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",53.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",61.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",61.8,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",67.9,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",71.4,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",79.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",89.2,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",97.5,,
"PHARCHLS","C10-Lipid modifying agents","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",110.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",11.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",11.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",10.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",10.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",9.8,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",10.4,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",10.5,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",10.3,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",10.2,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",22.7,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",24.9,,
"PHARANAL","N02-Analgesics","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",24,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",23.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",24.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",25.2,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",26.7,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",27.3,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",27.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",29.4,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",30.5,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",32.6,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",33.9,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",35.1,,
"PHARDEPR","N06A-Antidepressants","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",37.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",52.1,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",50.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",51.4,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",52.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",53.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",56.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",61.7,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",65.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",72.9,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",77.8,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",81,,
"PHARSKEL","M-Musculo-skeletal system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",70.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",32.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",43.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",35.1,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",37.7,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",40.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",44.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",50.4,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",54.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",60.3,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",65,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",67.8,,
"PHARPEPT","A02B-Drugs for peptic ulcer and gastro-oesophageal reflux diseases (GORD)","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",77.6,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",8.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",9.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",10.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",11.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",13.5,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",13.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",15.1,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",16.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",18.3,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",20.4,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",22.2,,
"PHARHYPO","C02-Antihypertensives","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",23.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",366.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",330.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",346.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",354.7,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",375.1,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",376.8,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",383.5,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",386.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",387.6,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",502.3,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",518.4,,
"PHARCARV","C-Cardiovascular system","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",541.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2010","2010",75.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2011","2011",77.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2012","2012",79.2,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2013","2013",78.6,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2014","2014",78.3,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2015","2015",78.8,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2016","2016",75.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2017","2017",72.9,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2018","2018",67.7,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2019","2019",66.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2020","2020",64.4,,
"PHARCCBR","C08-Calcium channel blockers","NBPYEANB","Defined daily dosage per 1 000 inhabitants per day","HRV","Croatia","2021","2021",62,,
